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ABSTRCT
Human immunodeficiency virus typ 1 (HV -1) infections have different
patterns of expression in different T-cell lines. mv -1 encodes regulatory as well
as strctural genes. The role of HN -1 regulatory gene expression in determining
different patterns of infection was explored in four T-cell lines: C8166 , H9 , A3.
and Jurkat. The hypthesis being tested was that differences in the expression of
regulatory genes would determine differences in the kinetics of infection.
To study patterns of regulatory and structural gene expression , RNA was
isolated from cultures infecte with HIV- NU- (NU-3). During the ealy and
acute phases of infection, the absolute amounts of viral RNA differed in the four
T-cell lines. However, the relative proportons of messages for regulatory and
strctura genes were similar. Thus , differences in the kinetics of infection in
C8166, H9, A3.01 and Jurkat cells were not determined by differences in the
relative levels of expression of regulatory and strctural genes.
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Analyses of RNA samples from the chronic phase of infection reveaed the
consistent appeance of novel RNase sensitive sites in H9 and Jurkat cultures.
These marked the emergence of vira varants with high abilty to establish
chronic virus producers. These varants were speificay selecte in the chronic
phase since they did not undergo selection during serial passage of the virus
though the lytic phase of infection. Sequence analysis of the region with the
novel RNase sensitive sites reveaed the co-mapping of nucleotide changes with
each of the novel sites. Most of these differences represented a sense mutation in
tat and the abrogation of the intiator methionine of vpu. However, the selected
mutations in tat and vpu were not sufficient , by themselves , to affect the abilty of
NI- to establish chronic virus producers (Chapters I and II.
Further studies on the roles of viral sequences in the chronic phase of
infection were underten using constructed virses. Two molecularly cloned
viruses NI- and mV- HXB-2 (H-2), were used as parents. NI- has a
low abilty to establish chronic virs producers. In contrast, HX-2 has a high
abilty to establish chronic virus producers. NI- encodes all known HI-
genes , whereas HXB-2 is defective for three auxilar genes: vpr, vpu and nef.
In addition , both viruses differ at other positions throughout the genome. The
first series of constructed viruses tested whether differences in auxilar gene
expression determined differences in the abilty of NI- and HXB-2 to establish
chronic virus producers. NI- mutats contaning all possible combinations of
the three defective genes in HXB-2 were constrcted. Analysis of the abilty of
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these mutats to establish chronic virs producers reveaed that vpr and net limit
the abilty of NU- to establish chronic virs producers. This was shown by
virses with defects in both of these genes having high abilty to establish chronic
virs producers (Chapter III).
The second series of constrcts tested for the roles of non-auxilar as well
as auxilar gene sequences on chronic virus production by creating recombinants
between NU- and HXB-2. Tests of these recombinants reveaed that gag, pol,
vi/, and vpr fragment could affect the abilty of fragments contaning defective
auxilar genes to establish chronic virus producers. Taken together, these results
indicate that vpr, net, and 5' internal sequences play importt roles in
determining the abilty to establish chronic virus producers (Chapter IV).
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INODUCTION
INODUCTION
Human Immunodeficiency Virs (H- l) is the etiologica agent for the
Acquired Immunodeficiency Syndrome (AIDS). CD4( 
+) 
T-cells are the prime
taget of the vira infection in this syndrome. Most infections of CD4( +) T -cells
are cytopathic. However, in some instaces, the virus ca establish itself in T -cells
and produce progeny without causing cytopathicity and death. Studies presented
in ths thesis were directed towards understading the role of HIV -1 genes in the
abilty of the virus to establish cells that are chronic virs producers. The
following introduction provides a broad overview of the virus itself and the disease
that it causes. It ends with a perspetive on why we chose to study viral
determinants that affect the abilty to establish chronic virs producers.
HIV -1 Viron Structure and Genome Organition
HIV - 1 is a member of the Lentivirina subfamily of the family Retroviridae
(Bare-Sinoussi et al. , 1983; Gallo et al. , 1984). It is an envelope RNA virus
which is approximately 100 nm in diameter (Figure I). The HIV-l virion contans
two strands of genomic RNA which are assembled as a nucleoprotein within a
toroidal capsid. In addition to the genomic RNA , the capsid contans three viral
enzymes that are necessar for ealy and late steps in the viral life cycle. These
include, the reverse transcriptase for DNA synthesis , the integrase for the
integration of the provirus into the cellular genome, and the protease that cleaves
precursor viral proteins to their mature forms. In addition, the capsid contans
the primer tRA Lys neeed for reverse transcription. The capsid is surrounded by
a lipid membrane derived from the cytoplasmic membrane of the host cell. The
lipid membrane contans the viral envelope glycoproteins (for recent reVIews see
Chatterjee, Basa, and Khan, 1992 and Kessler et al. , 1992).
HIV nome: pol flnv
p55 gp160
p6611 p31
p15 p24 p17 gp41 gp120
gp41 en.
pH 
Major HIV-1 Protelns in Western Blot Analysis
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genomic RNA/p15
Fig 1. Structural charcteristics of HIV -1 (Figure adapted from Kessler et aI., 1992).
The mv -1 genome organization is similar to that of other retroviruses.
The 9.2 kb single strded RNA genome resembles cellular mRNAs in that it has
a 5' cap (Gppp) and a 3' poly (A) tal. At each end of the genomic RNA are short
repets (R) and unique 5' (U5) and 3' (U3) seuences. These contan importt
regulatory elements involved in reverse trscription
, integration, transcription
and poly-adenylation. Sequences immediately adjacent to U5 encoe the primer
binding site (PBS) for (-) strd DNA synthesis whereas sequences immediately
adjacent to U3 encode the PBS for 
(+) 
strd DNA synthesis. Sequences thought
to be importt for packaging of the vira RNA into virions are also locted nea
._-
U5. The integrated virus is a double stranded DNA speies contaning long
termnal repet seuences (LTRs) at both ends. Each LTR consists of a copy of
the U3, R, and U5 seuences. In between the LTRs are sequences encoding the
strctura and regulatory genes of the virus (Figure 2).
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core proteins
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infectivity of
cell-free virus
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efficient
virion budding
and env processing
Viral-envelope
proteins mediating
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(gp120) membrane
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structural gene
expression
Binding sites
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transcription
factors
Figure 2. Genomic organzation of HIV -1 and overview of the known fuction of each geneproduct. LTR, long termal repet; TAR, tras-acting resnsive element (Figure adpted fromFeinberg and Greene
, 1992).
Expresion of Virl Genes
HIV-l is a prototypic complex retrovirus (Cullen
, 1991b). Complex
retroviruses express a number of gene 
products other than gag, pol, and env.
HIV-l uses differential splicing, frameshifting and ribosome scanning to express at
least nine gene products from a single RNA transcript. These include two
strctura polyproteins (Gag and Env), a polymerase polyprotein (pol) and at least
six maturational or regulatory proteins (Figures 2 and 3). The Gag and Pol
polyproteins are encoded by an un spliced 9.2 kb RNA. Five to 10% of the
petides initiated at the Gag AUG undergo frameshifting to produce Pol-speific
products (Jacks et al. , 1988; Wilson et al. , 1988). A 4-5 kb class of mRNAs
encodes the Env polyprotein and the maturational proteins Vif, Vpr and Vpu
(Muesing et al., 1985; Rabson et al., 1985; Arrgo et al. , 1990; Schwar et al.
1990a and b; Furtdo et al. , 1991).
HIV- mRNAs
fA'
;\ 
rev e
;; ,
\1lil#
netgag
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Figur 3. HIV -1 splicing patterns. The HIV -1 genome is shown at the top with the coding exons
shown as boxes, Bold lines depict the mature mRAs with their coding potential(s) shown along
the sides (Figure adpted from Schwartz et at. , 1990a).
Approximately 5 and - 5kb speies encode Vif and Vpr respetively (Arrgo et
aI., 1990; Schwar et al. , 1990a and b; Furtdo et al. , 1991). Vpu and Env are
encoded by a bicistronic - 4 kb RNA (Argo et al. , 1990; Schwar et al., 1990b;
Furtdo et al. , 1991). A 2 kb class of RNAs expresses the regulatory proteins
Tat, Rev, and Nef (Bnko et al. , 1990; Guatell et al. , 1990; Robert-Guroff et al.,
1990; Salfeld et al., 1990; Schwar et al. , 1990a; Furtdo et al. , 1991). The 5'
non-coding sequences for the 2 kb RNAs include different combinations of at
least 3 smail non-coding exons. Splicing events distinguish the translation of these
2 kb mRAs with the AUG immeditate to the 5' splice site determining the sites
for protein synthesis (Schwarz et al. , 1990a; Furtdo et al. , 1991).
Structural Genes: gag, pol, and env
The Gag and Pol proteins of the virus are produced as precursor molecules
that are cleaved into the mature virion forms during virus maturation (Figures 1
and 2) (for reviews , see Chatterjee, Basa, and Khan , 1992 and Kessler et al.
1992). The gag region encodes the Gag precursor polyprotein, Pr55 , that is
endoproteolytica1ly cleaved to form the strctural proteins of the virus. These
include the myristoylated matrx protein (P17), the capsid protein (P24), and the
nucleoapsid proteins (p7 and p9). The pol region encodes enzymes necessa for
virus replication. The Pol precursor polyprotein, Pr160 , is cleaved to generate the
viral protease (PlO) (required for virus maturation), the reverse transcriptase
(P66/51) (required for viral DNA synthesis), and the endonuclease/integrase
(P31) (required for provirus integration). The env gene encodes a polyprotein
gpl60 that is cleaved in the golgi to form the extracellular glycoprotein (gpI20)
and the transmembrane glycoprotein (gp1). The gp120 subunit of the Env
protein contans the binding site for the virus recptor, the CD4 molecule. The
gp1 trs-membrae protein is involved in the fusion of viral and cellular
membranes.
Regulatory and Accesory Genes
The regulatory and accessory genes of HIV -1 can be grouped into two
categories based on their formation by single (vif vpr and vpu) or multiple (tat,
rev, and nef) splicing events (Figures 2 and 3). Of these, only tat and rev are
essential for virs replication. The roles of the other gene products are not
clealy understood and frequently disputed.
tat
Tat, an 86 amino acid , 14 kd nuclea protein, is a potent trans-activator for
the transcription of proviral DNA (Arya et al.
, 1985; Sodroski et al. , 1985a and b;
Dayton et al. , 1986) (Figure 2). Tat functions by binding to TAR
, a cis-acting
RNA stem-loop strcture at the 5' end of al HIV- I mRAs (Rosen, Sodroski
and Haseltine, 1985; Muesing, Smith , and Capon; 1987; Feng and Holland, 1988;
Berkhout, Silverman, and Jeag, 1989; Dingwall et al. , 1990; Calnan et al. , 1991;
Weeks and Crothers, 1991). TAR functions only in the correct position and
orientation (Selby et al. , 1989). Tat has been proposed to modulate transcription
by increasing the rate of initiation as well as the efficiency of the elongation of
viral transcripts. Tat acts by binding to a U-rich bulge in the TAR element.
According to the RNA enhancer model, ths binding faciltates the initiation of
subsequent rounds of transcription by Tat. Tat' s effect on the rate of initiation is
affected by the basa rate of LTR-directed transcription and is apparent only when
the basa rate is low (Lspia, Rice, and Mathews, 1990; Kessler and Mathews
1991). Increasing evidence indicates that Tat also acts to stabilze the elongation
of viral trscripts by RNA polymerase II (Selby et al. , 1989; Laspia, Rice, and
Mathews, 1989; Marciniak and Shar, 1991; Kessler and Mathews. , 1992). In
addition to functioning through an RNA binding site, Tat can function when
bound to upstream promoter DNA (Southgate and Green, 1991). Tat requires
cellular factors for acting through both RNA and DNA elements (Marciniak et al
1990; Gatignol et al. , 1991; Southgate and Green, 1991). In the absence of Tat
the HIV- LTR has very low activity (Dayton et al. , 1986; Fisher et al. , 1986).
rev
The 19 kd Rev protein is the second essential regulatory gene of HIV-
(Figure 3) (Feinberg et al. , 1986; Sodroski et al. , 1986b). Primarly local 
the nucleus and the nucleolus , Rev controls the synthesis of viral structural
proteins (Figures 2 and 4). In the nucleus , Rev inhibits the splicing and/or alows
the export of un spliced and singly-spliced HI -1 mRNAs (Malim et al. , 1988;
Argo et al. , 1989; Emerman et al. , 1989; Felber et al. , 1989; Hadzopoulou et al.
1989; Hammarskjold et al. , 1989; Malim et al. , 1989a and b). In the cytoplasm , it
increases the translation of HIV- mRNAs (Arrgo and Chen. , 1991; Cochrane et
al. , 1991). Like Tat, Rev requires a cis-acting sequence, the Rev Responsive
Element (R), for both of its activities (Malim et al. , 1988; Rosen et al. , 1988;
Argo et al., 1989; Emerman et al. , 1989; Hammarskjold et al. , 1989; Malim et al
1989b) (se below). Formation of multimeric Rev strctures are required for Rev
binding to the RR (Olsen et al. , 1990; Malim and Cullen, 1991; Zap et al.
1991).
The RR is a complex seconda RNA strcture present in the env coding
Nucleus
Transcription
RRE
Nuclear Export 
RRE
RRE 
.. ,
-c l "
Translation
''''
Translation
Structural Proteins
Rev
Fige 4. Model for the bimodl Rev fuction. Rev is tralate from an RNA that doe not
depd on Rev for expression. Rev loclize in the nucleus where it binds to RR-contag
RNAs, promoting their export from the nucleus. Rev remain bound to the RNA durig trasprt.
Once in the cytoplasm, Rev would allow the assoiation of the RNA with the traslational machiery
of the cell (Figure adpte from Argo, Heaphy, and Haines, 1992).
region of the vira genome (Figure 2). It is present in the unsplice , 9.2 kb , and
the singly spliced , 4-5 kb, classes of mRAs , but is removed by splicing from the
multiply spliced 2 kb class of mRNAs (Figure 4) (Arrgo et al. , 1989; Felber et al.
1989; Hadzopoulou-Cladaras et al. , 1989). Rev controls the trsport of the 9.
- - - -"---_..
and 4-5 kb classes of mRNAs by binding to the RR (Daly et al. , 1989; Zap and
Green , 1989; Felber et al. , 1990; for review, se Feinberg and Greene, 1992).
When levels of Rev are low (such as ocurs ealy in infection or in cell lines in
which an infection is latent), 2 kb mRNAs predominate (Guatell et al. , 1990; Kim
et al. , 1989; Pomerantz et al. , 1990). When levels of Rev are high , the 9.2 kb
mRA can become the predominant speies (Km et al. , 1989; Pomerantz et al.
1990). Since Rev requires multimerization for binding to the RR, levels of Rev
that are below the threshold for multi mer formation (such as occur ealy in
infection) can prevent the synthesis of viral strctural proteins (for review see
Pomeratz, Bagasra, and Baltimore, 1992) (see below).
The net gene of HIV -1 is the most 3' coding sequence of the viral genome.
Its coding sequences parally overlap the 3' LTR (Figure 2) (Allan et al. , 1985;
Ratner et al. , 1985b). Like Tat and Rev, Nef is an ealy gene product (Guatell et
, 1990; Schwar et al. , 1990a; Hewlett et al. , 1991; Klotman et al. , 1991). Of
the three multiply spliced mRNAs, Nef message is the most abundant in T 
-cells as
well as monocyte/macrophages (Guatell et al. , 1990 , Robert-Guroff et al. , 1990;
Klotman et al. , 1991). The role of Nef is highly disputed and not clea (reviewed
in Hovanessian, 1992). However, the fact that a Nef open reading frame is found
in all primate lentiviruses suggests that this gene has an importt function in the
lentivirus life cycle in vivo (Cullen, 1991a).
The biologica significance of Nef in vivo has been demonstrate in the
----
SIV/rhesus monkey model (Kestler et al, 1990 and 1991). In this model, Nef is
essential for the maintenance of high viral loads and the induction of
immunodeficiency. A premature stop codon is rapidly selecte for a sense codon
in infecte animals with the resulting Nef-expressing virus causing
immunodeficiency. By contrast, virus with a nef deletion (a mutation that cannot
revert) is unable to cause immunodeficiency.
The most pronounced effects of Nef in cell culture are on the cellular
factors involved in the activation of T -cells and monocyte/macrophages and not
on virs replication. Nef down regulates the viral receptor, CD4 , from cell
surfaces (Garcia and Miler, 1991), limits the abilty of mitogens to activate the
transcription of the lymphokine, interleukin-2 (I-2) (Luria , Chambers, and Berg,
1991), and inhibits the induction of nuclea factor kB (NkB) by T-cell mitogens
(Niederman et al., 1992). This has lead to the suggestion that Nefs tagets may
be the infected cell and not the virus itself (Feinberg and Greene, 1992).
vif, vpr, an vpu
Roles of Vif, Vpr, and Vpu, in the virus life cycle are not clea (Figure 2).
Two of these proteins, Vif and Vpu , may be importt for virus maturation. The
viral infectivity factor, Vif, is a 23 kd protein (Kan et al. , 1986; Sodroski et al.
1986c). An open reading frame corresponding to vif has been observed in all
primate, feline, and bovine immunodeficiency viruses as well as such lentivirses
as visna-maedi (for references, see Fan and Peden, 1992). Vif is thought to act by
increasing viral infectivity during virs production (Fisher et al. , 1987; Fan and
Peden, 1992; Gabuzda et al. , 1992).
Vpr is a 15 kd, 96 amino acid protein (Wong-Sta, 1987) (Figure 2). It is
the only non-essential HIV -1 protein that is associated with the virion (Cohen et
al., 1990a; Yuan et al. , 1990). Multiple Vpr proteins are found in each virus
parcle and the protein is thought to be a dimer (Cohen et al. , 1990a; Gras-Masse
et al. , 1990). Non-pathogenic strains of simian immunodeficiency viruses
, such as
SIV cpz and SIV mod' do not contan the 
vpr open reading frame (Fukasawa et al.
1988). Vpr can weay trans-activate the HIV- LTR as well as heterologous viral
promoters (Cohen et al. , 1990b). It does not seem to act through a cis-acting
element and is thought to function by interacting with cellular proteins for trans-
activation. Vpr can increase the rate of viral 
replication and the level of viral
protein expression as well as the cytopathicity of infection for T-cells (Cohen et
al. 1990b). The C-terminus of Vpr is essential for activity and is rich in arginine
residues which could be involved in binding to RNA (Yuan et al. , 1990). No
speific function for Vpr has been associated in T-cells. However
, Vpr appes 
increase monocyte/macrophage tropism (Hattori et al.
, 1990; Westervelt et al.
1992). Preliminar data indicate that Vpr may have importt functions for the
maintenance of high viral loads and induction of immunodeficiency in infected
animals (Lg and Fleckenstein, 1992).
Vpu is a 16 kd integral membrae phosphoprotein importt for the
release of virus paricles from infected cells (Figure 2) (Cohen et al. , 1988;
Strebel, Klimkat, and Marn, 1988; Strebel et al., 1989; Terwillger et al. , 1989;
Klmkt et aI., 1990). Vpu shares seuence homology with the membrane-
assoiate M2 protein of influenza virs (Strebel , Klmkat, and Marn, 1988).
M2 has been shown to be an ion chanel (pinto , Hoslinger, and Lamb, 1992).
Vpu and Env are translate from a bicistronic mRNA suggesting a cordinant
interaction of the two proteins (Argo et al. , 1990; Schwar et al. , 1990b). Ths
is consistent with Vpu increasing the processing of the Env precursor gp160 by
disruptig complex formation of the Env precursor with the viral receptor
molecule, CD4 (Wiley et al., 1992a). Vpu dissociates gp160 from CD4 by
inducing the degradation of CD4 in the endoplasmic reticulum (Wiley et al.
1992b). Whether the abilty of Vpu to enhance virus parcle release is
functionaly related to its abilty to disrupt gpl60-CD4 complex formation remains
to be determined.
The CD4 molecule is the Receptor for HI-
Several lies of evidence indicate that CD4 is the major recptor for HIV-
1. Antibodies to CD4 molecules can block infection of otherwise permissive cells
(Dalgleish et al. , 1984; Klatzman et al., 1984). The viral envelope protein, gp 120
ca speifically bind to the CD4 molecule (McDougal et al. , 1986). Transfection
of human CD4( 
-) cells with the CD4 molecule results in the infection of these
cells by HIV-l (Maddon et al. , 1986). Finaly, soluble CD4 molecules as well as
synetc peptides of CD4 can block viral infection (Fisher et al. , 1988; Lifson et
al. , 1988).
..,
CD4-lndependent Inection of Cell
CD4 may not be the only recptor used by the virus for the entr procss.
HI -1 ca infect cells that do not express CD4 molecules such as cells of the
centr nervous system , cells in the bowel, human foreski fibroblasts, and muscle
cells (Lvy, 1989; Tateno et al. , 1989; Li et al. , 1990; Zack, Arrgo , and Chen
1990). Galactosylceramid on glial cell surfaces, the complement recptor CR2
and the Fc receptor gamma III on monocyte/macrophages have been implicated
as being alternative receptors for 
HN- (Takeda et al. , 1988; Tschachler et al.
1988; Clapham et al., 1989; Robinson, Montefiori, and Mitchell, 1990; Harouse et
, al. 1991).
Other cellular proteins may also be required for HIV - 1 infection since
HI -1 canot infect all CD4( +) human cells such as certn brain and skin cells
(Cheseboro et al. , 1990), nor can it replicate m murine cell lines transfected with
the CD4 molecule (Maddon et al., 1986). One line of evidence indicates that a
cellular protease, present in some but not all CD4( +) cells, may be required for
infection (reviewed in Putney, 1992).
HIV -1 Life Cycle
The overall HIV -1 life cycle is similar to that of other retrovirses.
Infection of permissive cells is initiated by the attachment of the virus to its
recptor, the CD4 molecule (Figure 5) (reviewed in Chatterjee, Basak, and Khan,
1992). Sequences in the viral envelope gp120 mediate binding of the virus to
CD4. Attachment is followed by the fusion of viral and cellular membranes. The
vi gp1 protein is involved in the fusion procss. Once the vira capsid is inside
. . c ce)1, the virion RNA undergoes reverse trscription by the virion-associated
reverse trscriptase to produce a double stranded DNA copy of the viral RNA.
Once inside the nucleus, the DNA integrates into the cellular genome using the
vion encoded integrase. The double stranded linea DNA molecule is the
precursor for integration. After integration, the vira genome becomes a cellular
gene that is replicated and expressed as other cellular genes. Vira mRNAs
Infecting
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Fige S. mv -1 vira life cycle. See text for detals.
trscribed from the integrated DNA are trsported to the cytoplasm for
trslation. The Gag precursor molecules become anchored at the inner surface
of the plasma membrae by the myristoyl moiety at their N-term. The Gag
precursors also bind genomic RNA by the zinc fmger domains found in the
nucleopsid proteins. Final assembly and maturation taes place durig budding.
Essential to maturation is proteolytic cleavage of the Gag and Gag-Pol precursor
polyproteins into their mature forms.
Control of HIV -1 Life Cycle
The HIV - 1 viral life cycle is controlled by both viral and cellular factors.
The most importt viral genes in ths control are the trans-acting, regulatory
factors tat and rev. Other viral factors like Vif and Vpr may also be involved in
the regulation of the HIV -1 life cycle, but since the functions of the genes are not
clea, their roles in this regulation are also not clea.
Tat contol of HW-l gene exression
Tat is a positive regulatory factor of LTR-directed gene expression
(reviewed in Cullen, 1991a; Feinberg and Greene, 1992). The HIV- LTR is
transcriptionally inactive in most cells. But once cells are stimulated (by
mitogens, for example), the LTR produces small amounts of multiply spliced
RNAs which include messages for Tat. Newly synthesized Tat upregulates its own
production as well as that of all the other HIV-l proteins. Tat acting on the TAR
element is thought to be instrmenta in activating the virus from its latent state
in quiescent cells (see below).
Rev contl of HW-l gene exression
The TatiT AR activation loop of the virs interacts with another regulatory
loop involving the Rev protein (Figure 4) (Arrgo , Heaphy, and Haines, 1992).
Rev controls the trsition from ealy (regulatory genes) to late (regulatory and
strctura genes) gene expression by controllng the extent of splicing (reviewed in
Zack, Argo, and Chen, 1990; Cullen, 1991a; Feinberg and Greene, 1992). As
Rev synthesis increases , Rev acts to alow the synthesis of viral structural proteins.
Ths diversion of RNA from regulatory to strctura genes limits the synthesis of
regulatory genes (Figure 4). Ealy in infection , when the levels of Rev are low
predominantly the multiply spliced 2 kb speies of mRNAs are made. With the
progression of infection , higher levels of Tat increase the level of expression of all
genes including Rev. Increased levels of Rev result in increased synthesis of the
5 kb and the 9.2 kb strctural mRNAs (contaning the RR) concomitat with a
decrease in the 2 kb regulatory mRNAs (lacking the RR). This pushes the
infection into the late phase resulting in the production of progeny virons.
The concerted action of Tat and Rev gives mv - 1 the flexibilty to establish
either a latent or a productive infection depending upon the activation or
differentiation state of the infected cell (see below).
LTR Contl of HW-l Lif Cycle
The HIV- l viral life cycle is influenced not only by the virus-encoded
regulatory factors , but also by the presence of host transcription factors. A
combination of viral and host factors ultimately determine the transcriptional state
of the vir genome which ca extend from being completely inactive to being
. fully active. HIV-l has achieved this level of control by the evolution of an LTR
that contas binding sites for a number of host cell transcription factors. Some of
these are constitutively expressed, while others are inducible (Figure 6) (for a
recnt review, see Reddy and Dasgupta. , 1992).
The initial rate of mv -1 provira DNA trscription is determined by
interaction of cellular factors with binding sites present nea the trscription sta
site in the LTR (Figure 6). The LTR has been divided into three functionaly
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distict regions relative to the transcriptional sta site: an upstream negative
. regulatory element (N), an enhancer region (ENH , and a down strea trans-
activatig region (TAR) (Figure 6). The NR has been shown to contan sites for
nuclea factors of activated T-cells , NFAT- l (Shaw et al. , 1988), upstream
stimulatory factor, USF (Garcia et al. , 1987), and AP- l (Franza et al. , 1988)
binding factors. The enhancer region includes a set of three tadem sites for
trscription factor Spl (Jones et al. , 1986; Garcia et al. , 1987; Harch et al.
1989), TAT A box factor, TFIID (Jokobovits et al. , 1988), two tadem binding sites
for nuclea factor, NFkB (Nabel and Baltimore, 1987), and the leader-binding
protein, LBP (Jones, Luciw , and Duchange, 1988). The TAR region includes a
site for the CCAAT binding protein , CTF/NF-l (Jones, Luciw , and Duchange
. 1988) and the TAR binding proteins , UBP-l and EBP-l (WU et al. , 1988). In
addition to these sites , the LTR contans three sites for the proto-oncogene
product Myb , one of which is contaned within the NR, one within the enhancer
region , and one upstream of the trans-activation region (Dasgupta et al. , 1990).
Thee of these transcription factors have been shown to have major effects
on LTR-dependent transcription. Two of these are constitutively expressed, while
one has tissue speific and inducible expression. Spl and TFII are the
constitutively expressed cellular transcription factors importt in mediating
promoter function of many cellular and viral genes (for a review see Lewin, 1990).
Both are critical to the functioning of the mV- LTR in vitro and deletion of
their
. binding sites results in a defective HIV - I provirus in cells without NFkB
""---"--
expressio (Jakobovits et al. , 1988; Lenard et al. , 1989).
NFkB is importt for tissue speific and inducible gene expression
espeialy during the activation of restig T -cells (Nabel and Baltimore, 1987;
Tong-Staks , Luciw , and Peterlin, 1987; Bohnlein et al., 1988). Thus , T-cell
activation allows transcriptional activation of the HN - 1- L TR. Ths has led to the
hypthesis that intracellular levels of activated NFkB may determne whether the
integrated HIV -1 provirus wil undergo an active lytic life cycle or a latent one
(Nabel and Baltimore, 1987; Tong-Staksen, Luciw, and Peterlin, 1987). NFkB is
also importt in cells of the monocyte/macrophage lineage since mature
macrophages constitutively produce NFkB (Griffin et al , 1989). Phorbol esters
and mitogenic lectins as well as tumor necrosis factor alpha (TNF-alpha) and
interleukin- l (IL- l) activate mV-l production in T-cells by acting through NFkB
(see Zack, Arrgo, and Chen , 1990 for references). However, NFkB binding sites
are not essential for viral replication since mv -1 can replicate in cells that do not
produce significant levels of NFkB (Maddon et al. , 1986). In addition, deletion of
both NFkB sites in the HIV- LTR has little effect on the replication of the virus
in activated periphera blood lymphocytes (PBLs) (Lnard et al. , 1989). Thus
NFkB probably acts to enhance the rate of viral transcription in cells responding
to mitogenic stimuli (see below).
Clical Stages of HIV -1 Inection
Aquired Immunodeficiency Syndrome (AIDS), the pathological
consequence of HIV -1 infection, initiates as a self-limited, acute viral syndrome
that develops into a long, clincaly asymptomatic stage, ending with the
development of severe immunodeficiency in the infecte individual and eventual
death (for recnt reviews , see Feinberg and Greene, 1992; Kessler et al. , 1992).
Detaled analysis of each period is described below.
Th Eily Acue Period
AIDS is charcterized by an ealy acute phase of infection which ca have
high levels of virus replication (Figure 7). During this ealy phase (lasting for a
few weeks), the infected individual may experience flu-like symptoms including
fever, headaches, lymphadenopathy, and rash. Plasma viremia of up to 1cr
tissue culture infectious doses (TCID)/ml may be observed with as high as 1 % of
circulatig CD4( +) cells becoming infected (Clark et al. , 1991; Daa et al. , 1991).
During the acute phase, a shar decline in the numbers of CD4( +) cells may
occur (Figure 7) (Clark et al. , 1991).
Th Long Astomac Period
The high plasma viremia observed in the ealy acute phase of the disease
falls with the appeaance of cytotoxic T -cells and antibody responses to the
infection (Figure 7). The length of the asymptomatic period, from seroconversion
to developing AIDS , vares with a median of - 12 yeas. Some individuals (such
as transfusion-related cases in children) develop the disease within a yea, while
others tae more than a decade. Throughout the asymptomatic period, virus
continues to replicate, but at a very low level in the peripheral blood (Coombs et
al. , 1989; Ho , Moudgil, and Alam , 1989; Bagnarell et al. , 1992; Michael et al.
1992). Vira replication is thought to be kept in check by the activation of the
hllmora and cellular ars of the immune system. Neutrizing antibodies to the
virs appe concomitat with the appece of cytotoxic T -cells , natura killer
cells, and antigen-presenting monocyte-macrophages. With the progression of the
disese, a gradual decline in the levels of CD4( +) T -cells is observed (50-100
cells/mm /yea) (Fahey et al. , 1990).
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The rapid seroconversion noted in infected individuals is primarly 
response to the strctura proteins of the virs. Ealy antibodies to Env include
isolate-speific neutrizing activity (Albert et al. , 1990). However, with disease
progression , vira varants emerge which are resistat to the neutrizing effects of
the ealy antibodies (Robert-Guroff et al. , 1986). As viral varants emerge with
new epitopes, a fresh antibody response is generated to these new vir epitopes.
These vir varants are no longer neutral by the ealier antibodies.
Patients in the long asymptomatic period have very low levels of infected
cells in the peripheral bloo with as few as 1 in 100 to 1 in 10 00 circulating T-
cells having viral DNA (Brinchman et al. , 1991; Saag et al. , 1991; Hsia and
Spetor, 1991). Of the DNA contaning cells, only one in 10 tyicay displays
vir antigens on its cell surface (Brichman et al. , 1991). With the development
of better tehniques like in situ PCR, higher percentages of infected cells have
been reported durig this phase with up to 1 % of the peripheral bloo
mononuclea cells now thought to potentially harbor HIV - 1 provirs (Bagasra et
al. 1992).
Periphera bloo contans only about 2 % of the tota body lymphocyte pol
(Feinberg and Greene, 1992), with the major reservoir of CD4( +) lymphocytes
being found in the lymphoid organs (tonsils , adenoids, and lymph nodes). Studies
of virus load in the lymphoid organs have reveaed that these tissues consistently
contan ten times higher proportions of infected lymphocytes than peripheral
bloo. This is true for individuals from all stages of disease (Fox et al. , 1991;
Pantaeo et al. , 1991). Infection of the lymphoid tissues is thought to be
importt in the development of immune dysfunction.
Th Fina Syptomac Period
The symptomatic stage of disease appes as the immune system fails to
control opportunistic infections. High levels of virus replication reappe with the
virus load increasing ten times in the peripheral blood as well as the lymphoid
organs (psalidopoulos et al. , 1989; Schnittman et al. , 1989 , 1990a; Simmonds et
al. 1990). The levels of plasma viremia rise and ca exce TCID/ml (Figure
7) (Ho, Moudgil, and Alam, 1989; Schnittman et al. , 1990a; Saag et al. , 1991).
With the rise of viral antigens in plasma, there is a concomitat increase in the
rate of CD4( + ) T-cell declie. The host immune response is no longer able to
suppress virus replication, most likely due to the increasing severity of defects in
the immune system. The result is pathologies related to full-blown AIDS.
Imune Dysfunctions in the Inected Individuals
Disturbances in many facets of the immune system occur in infected
individuals. These include alterations in the numbers and functions of memory T-
cells , macrophages and B-cells (for references, se Kessler et al. , 1992; Feinberg
and Greene, 1992). The CD4(+) class of memory T-cells undergoes depletion.
Those that remai are compromised in their abilty to produce IL- 2 and in their
responsiveness to antigen stimulation. These latter defects are often deteted
before a decline in the numbers of CD4( +) cells ocurs. Impairment of
macrophage functions include defective intracellular killng, diminished abilty to
present processed antigens due to reduced expression of Class II HLA-
molecules, and increased production of tumor necrosis factor alpha. Functional
defects for B-cells are observed as ealy as three months post infection. These
include loss of mitogen-induced Ig synthesis and chronic B-cell activation.
Macrophages as Reservoir of HIV -1 in the Inected Individual
CD4( +) T -cells and macrophages are the major tagets of mv - 1 in the
infecte individual. Of these, macrophages are the major reservoir of HIV -1 in
solid tissues (Ho, Pomeratz, and Kaplan, 1987; for a recent review , se
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Pomeratz, Bagasra, and Baltimore, 1992). In situ DNA hybridization has
reveaed chronic infection of macrophages from the bone marow, lungs, lymph
nodes, skin, and the brain (Lvyet al. , 1989; Kessler et al. , 1992). Unlike T-cells
where viral maturation occurs at the plasma membrae, vir maturation in the
macrophage can occur at the endoplasmic reticulum as well as the cell membrane.
Thus, intracellular stores of virus in macrophages may act as reservoirs of virus
thoughout the body.
Quiescent T -cell as the Reservoir of Inducible Virs
In addition to macrophages, resting T -cells may also act as reservoirs of
HIV- l in the peripheral blood. Unlike the macrophages that can contan
complete progeny virions, resting T -cells are an inducible source of the virs.
Productive infection of T 
-cells is dependent upon the proliferative state of the
cells (Zagury et al. , 1986; Stevenson et al. , 1990c; Zack, Arrgo , and Chen, 1990).
The virus can productively infect stimulated but not un stimulated T -cells
(McDougal et. al. , 1985). In unstimulated cells, virus can enter and undergo
reverse transcription , but it cannot make progeny virions.
Th Pre-Integraton State of Laenc
Two states of viral latency have been reported in quiescent T 
-cells. In the
pre-integration state of latency, extrachromosomal HIV -1 DNA can be detected in
quiescent lymphocytes with PCR (Stevenson et al. , 199Oc; Zack et al. , 1990;
Pomerantz, Bagasra, and Baltimore, 1992). The state of this DNA is
controversial. According to Zack et al. , 1990, it is the result of inefficient
incomplete reverse trscription. These incomplete reverse transcripts are labile
and loose the abilty to produce progeny virions on mitogenic stimulation by 15
hours post infection (Zack et al., 1990 and 1992).
In contrast, Stevenson et al. , 1990 have shown extrachromosomal DNA in
resting T -cells to be complete reverse transcripts (Stevenson et al., 1990c;
Bukrsky et al. , 1991). This completely reverse transcribed. DNA is
transcriptionally active and can synthesize p24 Gag, Env, and Tat proteins
(Stevenson et al. , 1990b and c). In addition , it is stable and capable of integration
for up to two weeks (Stevenson et al. , 1990b and c). The reason for the different
results obtaned by the two groups is not clea.
Complete reverse transcripts also appe to occur in quiescent T -cells in
infected hosts. In the asymptomatic stage of infection, resting T -cells have been
shown to contan unintegrated, complete reverse transcripts (Bukrsky et al.
1991). This DNA retans the ability to integrate upon T-cell activation. By
contrast, in patients with full blown AIDS , an increasing proporton of DNA is
found in the integrated state.
The block giving rise to the pre-integrative state of latency in quiescent T-
cells may be due to a lack of necessa cellular factors in these cells (Zack et al.
1990; Stevenson et al. , 199Oc). These may include NFkB and protein kinase C
(PKC)-- two factors importt in T-cell activation as well as the activation of the
vir LTR and enhancement of Tat function. Tat' s potency may be enhanced by
PKC in infected cells (Jakoborits, Rosenthal, and Capon, 1990). Quiescent T -cells
conta low levels of both NFkB and PKC. Thus, low levels of these factors in
non-proliferating cells may be a possible mechanism of keeping HIV -1 infection
dormant til levels of these factors increase such as afer T-cell activation (see
Feinberg and Greene, 1992). Whatever the cause of the block, the abilty of
resting T -cells to become latently infected with HIV -1 is of significance as such
may be the major source of inducible virus in the peripheral bloo.
Th Post-Integraton State of Laenc
In addition to the pre-integration form of latency, a post-integration form
of latency has also been observed in T -cells both in tissue culture and in infected
individuals (pomerantz et al. , 1990; Pomerantz, Bagarsa, and Baltimore, 1992). In
contrast to the pre-integration form of latency, low levels of virus replication can
ocur in post-integration latency.
Post-integration latency has been characterize in the monocytic cell line
Ul and the T lymphocytic cell line ACH-2 (pomerantz et al. , 1990). In the
un stimulated state, these cells are found to be arested in an aberrant state of
RNA expression typical of cells in the ealy stage of infection. This state is
characterized by low levels of predominantly multiply splice 2 kb and some 4 kb
mRNAs with very low expression of the un spliced 9.2 kb mRNAs. The same
pattern of expression is observed in cells infected with Rev mutats (Feinberg et
al. 1986). Stimulation of these cells with mitogens relieves the block leading to a
productive vira life cycle. The block observed in these cells may be due to sub-
theshold levels of Rev. Mitogenic stimulation probably activates NFkB which in
turn activates the viral LTR. Small increases in the levels of all proteins
espeially Tat, then trigger the LTR-directe increase in the transcription of al
viral genes including Rev which removes the block and alows a productive vira
life cycle to ensue (pomerantz et al. , 1990; Pomeratz, Bagasra, and Baltimore
1992).
Preliminar work on HIV -1 speific RNA expression in the peripheral
bloo mononuclea cells (PBMC) at varous stages of the disease has provided
some evidence for the existence of regulatory gene-encoded latency in the infected
individual (Seshamma et al. , 1992). The ratios of the multiply 
spliced to un spliced
RNA were greatly increased in the asymptomatic individuals compared to
individuals with AIDS. Over 70% of the PBMC in the asymptomatic patients
seem to express multiply spliced but not un splice RNA. This is in contrast to
the AIDS patients where over 80% of PBMC express un spliced RNAs. Cells
expressing only multiply spliced RNAs may be spared by the immune system due
to the lack of expression of viral strctural proteins , thus providing another source
of an inducible reservoir of virus. More importtly, this reservoir should not be
sensitive to treatment with reverse transcriptase inhibitors since the 
virs has
already undergone reverse transcription (pomerantz
, Bagasra, and Baltimore
1992)
Dynamcs of HIV -1 Persisence with Dis Progresion
Thus, whether the viral latency is pre-integrative, post-integrative, or both
Il-I is able to persist in the infected individua for extended periods of time
and survive. Clinical latency, the asymptomatic stage of mv -1 infection, as
oppose to viral latency, is by no meas a state of absence of virus expression and
replication. Insted, it is characterized by low levels of virus production which
may be the result of pokets of " smoldering" infections in the infected individual.
These pokets may be exemplified by the lymphoid organs such as the lymph
nodes in which certn populations of cells are producing virs , while others are
latently infected with no virs expression or production. Circulating cells in the
bloo and lymphatic vessels passing through these centers of active virus
replication, may occasionally get productively infected and die releasing a constat
amount of virus. Thus, a certn virs load could be maintaned during the long
asymptomatic stage without completely depleting the mai taget cells and at the
same time causing immune dysfunction (Fox and Cottler-Fox, 1992).
Evolution of the Viral Genome
One of the hallmarks of retroviral infection is the evolution of the viral
genomes with time (Coffin , 1986; Goodenow et al. , 1989). Many mutations are
the result of the high error rate of reverse transcription. The viral reverse
transcriptase introduces 
- 1 misincorpration per genome per replication cycle
(Dougherty and Temin, 1988; Leider et al. , 1988; Goodenow et al. , 1989). The
error rate of the HIV -1 reverse transcriptase may excee that of other retroviruses
(Varian et al., 1992). The populations of related HIV-l genomes in a patient
(or a stock) over time are referred to as a "quasispeies (Steinhauer and
Holland., 1986; Gooenow et al. , 1989).
Sequence data of viral isolates from patients reveas heterogeneity of viral
genomes both within and among infected individuals. Within an individual at a
given time period, the quasi speies may var between 0-2 % of nucleotides (nts) in
env (Hahn et al., 1986; Saag et al. , 1988; McNeay et al., 1990). Vira genomes
var between 0-9% (of nts in env) among close contacts (Burger et al. , 1991; Balfe
et al. , 1990; McNeay et al. , 1990), and between 6-22% (of nts in env) among
isolates from unrelated individuals (Ratner et al. , 1985a; Alizon et al. , 1986;
Myers et. , 1990). Within one patient in a three-week period, the maximum
amino acid varation observed in a series of genes was: 14. 9% for env 1.0% for vif
and vpr 1.9% for Mf, 9% for tat 6% for vpu and 10. 2% for rev (Groenink et
al. 1992).
Degree of Defectivenes of HIV -1 Genes with Disease Progresion
Analyses of the degree of defectiveness of viral genomes from uncultured
patient isolates have reveaed that there are limited signs of defectiveness for
regulatory and accessory genes within the viral genomes present in vivo (Balfe et
al. , 1990; Delassus et al. , 1991; Marn et al. , 1991; Li et al. , 1991 and 1992;
Blumberg et al, 1992). Biological tests of cloned proviruses in animal model
systems have reveaed that there is selective pressure to preserve open reading
frames for at least two viral accessory genes vpr and Mf The functions of both
of these genes appe to be importt for the maitenance of high viral loads and
the induction of immunodeficiency (Kestler et al. , 1991; Lag and Fleckenstein
1992).
Increaed Virlence of HIV -1 Isolates with Dis Progresion
Biological analyses of viruses isolated from patients over a period of time
as well as patients from different disease stages , have reveaed increases in the
virlence of isolates with disease progression (Wong-Sta et al. , 1985; Cheng-
Mayer et al., 1988; Fenyo et al. , 1988; Meyerhans et al., 1989; Tersmette et al.
1988; Schwar et al. , 1989). Viruses isolated from the asymptomatic stage of the
disease are generally slowly replicating, non-syncytium inducing viruses that grow
to only low titers in primar cells and not at all in established cell lines. These
are the slow/low virses. With the progression of the disease, viruses isolated
from ARC (AIDS related complex) or AIDS patients ca replicate rapidly and to
high titers in both primar cells as well as established cell lines and can cause
syncytia (Asjo et al. , 1986; Cheng-Mayer et al. , 1988; Fenyo et al. , 1988; Tersmette
et al. , 1988). These latter isolates display not only higher cytopathicity, but also a
broadened host range.
Genetic Determants of Cytopathicity
Genetic analyses of the patient isolates have reveaed that the env gene is
the major determinant of cytopathicity (Sodroski et al. , 1986a; Cheng-Mayer et al.
1990; Koga et al. , 1990; Stevenson et al. , 1990a; York-Higgins et al. , 1990; Hoxie
et al. , 1991; Kowalski et al. , 1991; de Jong et al. , 1992). The major effect of Env
:"f
on . cytopathicity is due to its effect on the abilty of the virs to induce syncytia.
Speificay, the V3 (the third varable domai) loop within the gp120 porton 
the envelope protein has been implicated in the syncytium-
inducing capabilty of
the virs. Single amino acid substitutions altering positively charged residues
with this loop ca drastically affect the abilty of virs to induce syncytia (de
Jong et al., 1992).
However, other regions of the viral genome such as the 5' gag/pol
seuences, have also been implicated in determining the cytopathic potential of
the virus (Hirsch et al. , 1992; de Mareuil et al. , 1992). In addition, certn
auxiliar genes of the virus have been shown to influence the cytopathicity of the
virs. These include: tat (Cheng-Mayer, Shioda, and Levy, 1991), vif(Sak et al.
1991), vpr (Cohen et al. , 1990b), and vpu (Terwiliger et aI. , 1989). The fact that
cytopathicity can be modulated by such a varety of genetic elements suggests that
there may be several mechanisms for cell killng.
Mechanim of HI - Induced Cytopathicity
As apparent from the fact that many regions of the virs have been
implicated in the cytopathic potential of a virus , cytopathicity is not a well
understoo phenomena. Syncytium formation ca cause cell death (Sodroski et
al. , 1986a). Cell death can also occur in the absence of syncytium formation
(single-cell killng) (Somasundaran and Robinson, 1987; Lenard et al. , 1988;
Tersmette et al. , 1989). Fusion of infected cells with uninfected cells leads to the
formation of syncytia. The viral envelope glycoproteins expressed on the surfaces
of infecte cells interact with the CD4 receptor on the surfaces of adjacent
unifected cells resulting in the formation of multi-nuclea giant cells (Lifson et
al., 1986; Sodroski et al. , 1986a; Stein et al., 1987; Rusche et al. , 1988; Kowalski et
al., 1991). This explais why Env protein has been found to be the major
determnant of cytopathicity of viruses in cell culture.
Though syncytium formation is amply observed in cell culture with most
cytopathic HIV -1 isolates, few syncytia have been observed in vivo in the lymph
nodes of patients with AIDS and none has been observed in the peripheral blood
(Rcz et al., 1986). In addition in vitro cell death has been observed in the
absence of syncytia (Somasundaran and Robinson , 1987; Cloyd and Moore, 1990)
and syncytia have been observed without cell death (Stevenson et al. , 1990a; Sak
et al. , 1988). Thus , cell fusion may not be a very importt determinant of cell
death in vivo.
Death by single-cell killng could result from many factors including: i)
death by disruption of cellular membranes due to massive viral budding (Lnard
et al. , 1988); ii) viral protein products causing disruption of cellular functions
(Hoxie et al. , 1986; Koga et al. , 1990) or ii) direct toxicity due to the intracellular
accumulation of viral protein products (Stevenson et al. , 1988; Terwiliger et al.
1989). These observations, once again , point to the complex nature of
cytopathicity" and emphasize that no one mechanism or determinant can explain
its basis.
In short, HIV -1 is a complex retrovirus capable of using an intricate web of
both at the cellular and viral levels , to ensure its long term
suMyal. Ared with Tat and Rev , it is capable of a latent or a productive
infection depending upon the cell typ it infects and the proliferative and/or
. . - 
differentiation state of the cell.
Goals of the Thesis
Ths thesis was underten to study the role of regulatory genes in
determng different kinetics of replication of HI - 1 in T -cells. Preliminar work
had shown that both the virus and the cell line affected the kinetics of mV-
expression in culture. At the time, very little was known about the nature of the
regulatory genes and the hypothesis had been presented that regulatory genes
controlled the tempo of virus replication. Based on this , our hypthesis was that
differential expression of viral regulatory genes would determine the kinetics 
virs replication in T-cell lines.
Actual analyses of the temporal expression of regulatory and strctura
genes reveaed that regulatory genes were not determining differences in the
tempos of infection in T-cell lines (Chapter I). Durig these studies , novel RNA
frgments were observed in the chronic phase of infection. These fragments were
characterized and shown to reflect the emergence of viral varants (Chapters I).
Characterization of the varants reveaed that they had enhanced abilty to
generate chronically infected , virus producing cells (chronic virus producers)
(Chapter II. Studies in Chapter II also identified two molecularly cloned virses
with different abilties to generate chronic virus producers. In Chapters III and
IV, these two viruses were used to map HIV -1 seuences that affect the abilty to
cc==c establish chronic virus producers. Results of these analyses reveaed that the
abilty to establish chronic virus 
producers is affected by vpr, nef,and a 5'
frgment encoding gag, pol, vif and vpr.
MATERI AN METHODS
MATELS AN :MTHODS
CELLS: C8166 H9 (American Ty Culture Collection, ATCC TI 161),
Jurkat clone 8, and A3.01 cell lies were obtaned from the NIAID AIDS
Repository (Rockvile, MD). Cells were maitaed at densities of 0.5 to 2X10
cells/ml in RPMI 1640 supplemented with 10-20% feta bovine serum , penicilln
and streptomycin (growth media).
DNA CONSTRUCTS: Parental DNAs: Viruses HN- NI- and mV- HX-
2 were obtaed as plasmids from the NIAID AIDS repository. pNI- 3 is a
laboratory constrct that was created by ligating the 5' half (ti the unique EcoRI
site) of mV- NY5 with the 3' half (from the EcoRI site onwards) of HIV-
LA V-I (Adachi et al. , 1986). The plasmid pHXB-2 contans a non-permuted
HN- DNA that was molecularly cloned from mV- IIIB infecte cells (Fisher et
al. , 1985).
NI3 Mutants: The Vpu(-)NI-3 (N U) was obtaed from K. Strebel. It
was created by insertng an 8 bp XhoI linker at the SspI site in the vpu gene
(Strebel , Klimkat, and Marn , 1988). The Nef(-)NI-3 (NL N) was obtaned
from S. Venkatesa. It was created by fillng-in the unique XhoI site in net
(Ahmed and Venktessan, 1988). The Vpr(-)NI-3 (N R) was created by
filing-in the EcoRI site in vpr using the Klenow fragment of E. coli DNA
Polymerase I. The EcoRI to BamHI fragment of the NL U mutat was
johaged with the homologous NLAN virs to generate the NLA U AN mutat.
::rQ reate the NLARAU, NLARAN, and NLARAU AN mutats
, the EcoRI sites in
vpr 
Qf the NLA U NLAN, and NLA U AN mutats were f1led-in with the Klenow
frgment of 
E. coli DNA Polymerase I. Restrction endonuclease sites that were
create or abrogated in constrctions were used to verify the presence of
mutations.
Nl3-HXB-2 Recombinants: Recmbinants between NI- and HX-2 were
constrcted using conserved 
ApaI EcoRI SalI , and XhoI sites to
interchange homologous regions. Constructions were verified using EcoRI NcoI
and I restrction sites that distinguish pHX-2 from pNI-3. Recombinant
DNAs were grown in E. coli HBlOl.
ANODIE: i) Leu 3a, a monoclonal antibody against the virus-binding region
(CDR2) of CD4 was obtaned from Beton Dickinson (Mountan View, CA); ii)
OKT4A , a monoclonal antibody against CD4 outside the virs-binding site (next
to CDR2) was obtaned from Ortho Diagnostics (Rarta, NJ); iii) a patient sera
from an mv -1 sero-positive individual for use in indirect immunofluorescence
assays (IF A) and western blot analyses was provided by Dr. J. Sullvan
(Deparment of Pediatrcs and Program in Molecular Medicine, University of
Massachusetts Medical Center , Worcester, MA); iv) IgG- , a poled sera from
HN 1 sero-positive individuals, for use in immunoprecipitations and western blot
analyses was obtaned from Abbot Laboratories (Chicago, IL); v) an anti-Vpu sera
faSe in rabbits against an E. coli derived fusion protein was obtaned from Dr.
. == _.-----
1Gaus Strebel (Lboratory of Molecular Microbiology, National Institute of
Alergy and Infectious Diseases, Bethesda
, MD).
VIL STOCKS: HIV- IIIb (lIT) was produce by serial passage of a stock
originaly obtaned from Dr. R. C. Gallo (Gallo et al. , 1984; Shaw et al. 1984).
ID- NI- (N-3) was recovered 4 to 6 days post transfection of H9 cells with
. .
pNI-3. HI- HXB-2 (HXB-2) was recovered 14 to 16 days post transfection of
H9 cells with pHXB-2. Transfections were cared out as described below. Stocks
were titered for infectious units on C8166 cells as described below.
STOCK TITIONS: Titers (infectious units) of virus stocks were determined
by infectig C8166 cells with serial dilutions of the test stock in the presence of 2
ug/ml Polybrene. Leu 3a (240 ng/ml) was added to cultures at 3 hours after
infection to prevent syncytium formation (Sattentau et al. , 1986). At 24 hours
afr infection , cells were assayed for the fraction expressing viral antigen by IF 
(se below). Stock titers were calculated as (prcentage of virus-expressing cells)
X (concentration of C8166 cells at the time of infection) X (test dilution). Titers
obtaed by this method agree well with those obtaned by endpoint dilution on
C8166 cells. The highest-titered stocks (- 10 infectious units per ml) were
obtaed from cultures undergoing a spreading infection. Multiplicities of
infection are given as C8166 infectious units per cell.
IJSFECTIONS AN INCTIONS: For transfections, 1 ug of plasmid
---
DNA was use per lXI0 H9 cells. For each transfection
, 10 exponentially
growig cells were used. Cells were 
washed in RPMI/Tris (RMI 1640 medium
buffered with 0. 1 M Tris-HCl , pH 7.5), trsinize in 0.025% Trysin
(Gibc/BRL, Grand Island , NY) for five minutes at room temperature, and
washed once in RPMI/Tris. Washed cells were resuspended in 2 ml of
RPMITris and incubated for 20 minutes at room temperature with 10 ug of
DNA and 400 ug DEAE-Dextran (200 ug/ml) (pharmacia, Sweden).
Trasfections were stoppe by adding a five-fold excess of growth medium. Cells
were washed once in RPMI/Tris before culture. The medium of transfected
cultues was changed daiy during the ealy and lytic phases of infection and on
alternate days during the chronic phase. At the time of feeing, cultures were
monitored for the numbers of live and dead cells using tran blue exclusion and
the percent of infected cells using IF A as described below.
Infections were caed out in the presence of 2- 10 ug/ml polybrene.
Cultues were washed at 24 hours after infection. As explaied above, infected
C8166 cultures were grown in the presence of 240 ng/ml of Leu3a. Both the
trsfected and infected cultures were fed daily during the ealy and lytic phases
of infection and on alternate days during the chronic phase of infection. At the
time of feeing, cultures were monitored for virus-expressing cells by IFA. Virus-
induce cytopathic effects were followed by scorig numbers of live (trpan blue
excluding) and dead (tryan blue staning) cells.
IRCT 
OFLUORECENCE ASSAYS : IFAs for the
----
etetion of viral antigen-positive cells were performed as follows: 2.
5Xlcf cells
were washed with phosphate buffered saine (PBS), suspended in 
fresh 20 ul PBS
and alowed to settle on 10-well silconize slides (Cell Line Associates, Newfield
NJ by seuentialy placing the 20 ul samples over a series of wells. 
Excess liquid
was removed after approximately one minute and the wells were allowed to air
dr. Slides were stored at room temperature till assayed for the presence of HIV-
1 antigens. HIV -1 antigens were detected by fixing the ai-dried cells for 5-
miutes at room temperature in methanol. Slides were washed with PBS and
fied cells incubated for 30 minutes at 37 C with an appropriately diluted heat-
inactivate (57 C, 30 minutes) serum from an mV- l-seropositive individual.
Aftr the fist incubation, the slides were agai washed three times with PBS and
incubate for 30 minutes at 37 C with an appropriately diluted fluorescein-
conjugated goat anti-human serum (H and L chain speific; Organon Teknika-
Cappel, Durham , NC). Finaly, the slides were washed three times with PBS and
mounted in 90% glycerin. Virs-positive and -negative cells were counted with a
Zeiss fluorescence microscope using a counting grid. Staned slides could be
stored at 4 C for several weeks.
FLUORECENCE-ACTIVATED CELL SORTING ACS ANALYSES: FACS
was Caed out using the OKT4A monoclonal antibody as described above. 1-
2X10 cells were washed twice in cold PBS and resuspended in 25 ul of cold
RPMI 1640 medium supplemented with 5% FBS and 0.2% Azide. Cells were
incubated with 5 ul of OKT4A (50 ug/ml) for 30 minutes on ice with intermittnt
mixing and washed twice with cold PBS. Washed cells were resuspended in 25 ul
of 1:20 dilution of fluorescein-conjugate anti-mouse IgG (H and L chain speific
Ortho Diagnostics, Rarta, NJ) and incubated on ice for 30 minutes with
intermittent mixing. After washing twice in cold PBS , cells were fixed in 200 ul of
fresh 2 % paraformaldehyde for 10 minutes at room temperature, washed once
more in PBS at room temperature, and resuspended in the azide-contaning
medium at 1-2XI0 /ml.
RNA EXTRCTIONS: Cellular RNAs were extracted by solubilzation of
washed cells in a 4 M solution of guanidine isothiocyanate (GIT) followed by
cesium chloride (CsCI) density fractionation (for reference see, Davis, Dibner, and
Battey, 1986). Solubilzed cells (5X10 /ml) were layered over a 4 ml cushion of
7M CsCI and centrfuged for 2.36 hours at 32 OOrpm in a SW41 rotor at 20
The RNA pellet was dissolved in 0. 3 M sodium acetate (pH 6.0), phenol
extracted, and precipitated by adding 2-3 volumes of 95% ethanol. The resulting
precipitate was collected by centrfugation and dissolved in diethylpyro-carbonate-
treated water. The optical density at 260 and 280 nm was determined and the
RNA was aliquoted and stored at - C as a 70 % ethanol slurr.
Virion RNAs were prepared by concentrating virion parcles using high
spe centrfugation. First, the viral stocks were cleaed of cellular debris by
centrfugati at 6 00 rpm for 30 minutes in the table top Sorval RT 60.
, . 
._u__. ons in the cleaed supernatats were pelleted by ultrcentrfugation in the SW
28 rotor at 20 00 rpm for 90 minutes at 4 C. The pellete virs parcles were
solubil in the 4 M GIT buffer and procssed for RNA extraction as described
for cellular RNAs.
RlOPROBES: Riboprobes were prepared from fragments of pNI-3 or pHX-
2 that had been subcloned into pBlueskrpt SK( +) (Stratagene, La Jolla, CA).
Riboprobes were produced by the modification of the protocol described by
Melton et al. , 1984. Briefly, 1 ug of lineazed template DNA was incubated with
excess GTP, ATP , and UTP (lul of 10 mM stocks), 12 uM of cold CTP (if used
for RNase protection assays), e p)CTP (800Ci/mmole) (50 uCi for RNase
protetion assays and 80 uCi for nortern blot analyses), appropriate buffers
RNase inhbitor (Rasin, Promega, Madison, WI, and bacteriophage T3 or T7
polymerase (promega , Madison, WI). The transcription mixtures were incubated
for one hour at 37 C for the polymerization of the probe and DNase treated
(DNase RQ1; Promega, Madison, WI) for 15 minutes at 37 C to remove any
DNA template. Radiolabeled RNAs were phenol extracted in the presence of
yeast tRA as carer, separated from unincorprated nucleotides by passing
though a Sephadex-G50 spin-column, analyzed for the amount of incorprated
radioactivity by Cerenkov counts and stored in water at 4 C if destined for RNase
protection assays , or in a 50% formamide buffer at - C if to be used for
nortern blot analyses. The size and integrity of radiolabeled RNAs were verified
by electrophoresis on 6% polyacrylamide gels prepared in the presence of 7 
urea (6% PAGE-1M urea).
NORTHER BWT ANALYSES: Thee to 5 ug of cellular RNAs were mixed
with 5 ug of ethidium bromide and separated on 1 % agarose gels in 2.2 M
formaldehyde and Ix MAE (0.2 M MOPS (PH, 7.0), 5 mM NaAc , and 1 mM
EDTA) for 16 to 20 hours at 24 volts with vigorous recirculation. Gels were
rised in water and photographed to visualize the positions and integrity of rRNA.
Using capilar action , transfer to Duralon membranes (Stratagene, La Jolla, CA)
was cared out for 16-18 hrs in 20X SSC (0. 3M sodium citrate, 3M sodium
chloride, pH 7). Transferred RNA was cross-linked to the fiters using two
exposures of 0. 12 Joules of UV iradiation in a Stratainker (Stratagene, La Jolla
CA). Prehybridizations were done for 3-4 hours at 55- C in 0.05 X dried skim
milk (Blotto)/50% formamide/6XSSC (Johnson et al , 1984). labeled
riboprobes were added to this solution at 1-2 x 10 cpm/ml and hybridized
overnght at 55- C. The fiters were washed thrce for 20-30 minutes each in
IX SSC/ 0. 1 % sodium dodecyl sulfate (SDS) at 67 C and subjected to
autoradiography for varable lengths of time using Kod X-OMAT fim. The
24- 5kb RNA ladder from Bethesda Reseach Laboratories (Gaithersberg,
MD) was used for sizing.
RNas PROTECTION ASSAYS: RNase protection assays were cared out by a
modificatio of the procedure of Zinn, De Maio, and Maniatis, 1984 as described
by Beberich and Stoltzfus, 1991. Speificaly, one to 20 ug of RNA was pelleted
dred, and dissolved in 35 ul of hybridization buffer (80% formamde, 40 mM
PIPES (PH 6.7), 400 mM NaCl , 1 mM EDT A) containg 2-3 x IOS cpm of 32
labeled riboprobe. The mixture was denatured at 95 C for 10 minutes and
immedately incubated at 45 C for 10-12 hours. Three hundred ul of RNase
digestion buffer (16 ug/ml RNase A and 2 ug/ml RNase Tl in 10 mM Tris-HCl
(PH 7.5), 5 mM EDTA, and 0.3 M NaCl) were added to each sample and the
reactions wt!re incubated at room temperature for one hour. Fifty ug of
:i; i::' ;i 
sUlfate were added and the samples incubate for 15 minutes at 37 C. Incubation
: :~~~:"; 
'f;
: .
proteinase K, 17 ul of 10% SDS and 3.6 ug of the ribonuclease inbitor polyvinyl
.. . .
. mitures were extracted once with 400 ul phenol, 2 times with 400 ul of
: " ~~~~
r' , chloroform and precipitated with 3 volumes of 95 % ETOH at room temperature
: .
:11
~~~ .' :
;1' , it(pthe presence of 20 ug of caer tRA. After a 70% ethanol wash at 0-
;,," 
\i. pellets were dried and the RNA resuspended in 5 ul of loading buffer (80%
::'
deiOni formamide, 5 mM EDTA, 0. 1 % each of bromophenol
~\, ':j'
ol dyes), denatured at 95 C for 10 minutes, and fractionated
blue and xylene
on 6% PAGE-
!J;ea sequencing gels at 1000 V for 4 hours. The gels were dried for one hour
00C and autoradiographed using Kodak X -OMA T fim for varable lengths of
. jh Denatured p end-labeled (using T4 polynucleotide kiase) pBR322-MspI
j'bacteriophage X174-HaeIII fragments were used as markers for sizing.
AMLIFCATION CWNIG AN UECING: Viron RNA was
reverse transcribed using an antisense (as) oligonucleotide primer spanning the
KpnI site at nt 6343 of pNU- provira DNA (Go et al. , 1990). The reverse
transcripts were PCR amplified using Taq polymerase and a sense (s)
oligonucleotide spanning the EcoRI site at nt 5743 of pNU- provir DNA and
the KpnI(as) oligonucleotide (Go et al. , 1990). PCR products were then
substituted into pNU- for the homologous EcoRI to KpnI fragment (see Figure
8 below and Figure 20 in Chapter TI). To accomplish this , the 2.73 and 12. 1 kb
EcoRI to BamHI fragments of pNU- 3 were isolated by separating the fragments
on a 1 % low melting point agarose gel. The 2. 73 kb fragment was KpnI digeste
and the 2. 13 kb KpnI to BamHI fragment was isolated as described above. A
three way ligation was cared out with this 2. 13 kb fragment, the 0. 6 kb EcoRI
and KpnI digested PCR products, and the 12. 1 kb pNU- fragment.
Recombinants were screened for intact provira DNA using KpnI and EcoRI plus
BamID digests. The PCR-derived region of recombinants was sequenced using
double strand DNA sequencing primed by anti-sense oligonucleotides (Sequenase
version II protocol, United States Biochemical, Cleveland , OH). The
oligonucleotides used for cloning and sequencing (and shown in Figure 20) were:
EcoRI (s) 5' GCCATAATAAGAATTCTGCAACAACTGC-
EcoRI (as) 5' GCAGTTGTTGCAGAATTCTTATTATGGC-
KpnI (s) 5' GTCTATTATGGGGTACCTGTGTGGAAGG-
(5733-5760);
(5760-5733) ;
KpnI (as) 5' CCTTCCACACAGGTACCCCATAATAGAC-
(6332-6359);
(6359-6332);
R K
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Figu 8. Clonig of the 600 bp PCR amplified frgments from the varant viru into pNI-
The EcRI to KDnI fragment ofpNI-3 was exchanged with the RT-PCR amlified 600bp
frgment from the variant viru. R, EcoRI; K, KpnI; and B, BamH restriction endonuclea site.
RT, reverse trascription; PCR, polymera cha reation.
Oligo a (as) 5' CAATAGCAATTGGTACAAGC-3' (5909-5890);
Oligo b (as) 5' TACTGCTTGATAGAGAAGC- (607-6028);
Oligo c (as) 5' ATGATTACTATGGACCACAC-3' (6140-6121).
PROTEIN EXTRCTIONS: Protein extrcts were made by the method of
Felber, Drysdale, and Pavlaks , 1990. In brief, cells were washed in PBS and lyse
in 0.5X RIPA buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 % Triton X- loo
1 % sodium deoxycholate, and 0. 1 % SDS) at 10 cells/mI. To prevent oxidation
and proteolysis , beta-mercaptoethanol was added at 50 ul/ml, leupeptin was
added at 2 ug/ml and phenylmethylsulfonyl fluoride at 1 mM. Nuclei were spun
down and supernatats (contaning the protein extracts) were frozen at -
S METABOLIC LABELING OF CELLS: Cells were metabolically labeled
using the procedure of Felber , Drysdale and Pavlaks , 1990. 5xl0 cells were
washed and incubated in 1 ml of cysteine- and methionine-free modified Eagle
medium (buffered with 12 uM N- Hydroxyethylproperazine- Ethane sulfonic
acid) for 30 minutes at 37 C. Cellular proteins were metabolicaly labeled by
adding 200 uCi/mI of Translabel (15% Cysteine and 70% 35
Methonine) and 200 uCi/ml of Cysteine (ICN, Radiochemicals, Irvine, CA)
for 3-4 hours at 37 C. Protein samples were prepared for immunoprecipitation
accrding to Felber, Drysdale, and Pavlaks, 1990 as described above.
IMOPRECIPITATIONS Immunoprecipitations were cared out by a
modification of the procure of Felber, Drysdale, and Pavlaks, 1990. Briefly,
celllysates were pre-cleaed with pre-immune human sera for 1 hour at 4 C and
protein- Sepharose beads (CL-4B; Sigma chemicals, St. Louis , MO) (15-20 ul
bed volume) in RIPA buffer for 30 minutes at 4 C. Cleaed lysates were
incubated overnight with the appropriate antibodies (1:400 dilution of IgG-
and 1:100 dilution of anti-Vpu sera at 4 C. Immune complexes were precipitate
with protein- Sepharose beads (4 hours at 4 C), and separated on 12-14% SDS-
polyacrylamide gels as described below.
WESTERN BWT ANALYSES: Proteins were separated on 12-14% SDS-
polyacrylamide gels using the denaturing-discontinuous buffer system of Laemmli
1970. Samples were boiled in SDS-contaning Laemmli buffer prior to loading
and run overnight at 8mA (gel size, llX14 cm). For sizing, the commercialy
available 14-200 kD Rainbow Markers from Amersham (Arlington Heights, IL)
were used. Gels contang 1abeled samples were fixed in 10% acetic
acid/30% methanol for 1 hour and treated with En hance (New England Nuclea
Dupont, Boston , MA) for another hour. After rinsing in water and drying,
treated gels were exposed to Kodak X-OMAT fim.
Gels contaning non-radiolabeled samples were prepared for wet
electrophoretic transfer onto nitrocellulose membranes (Schleicher and Schuell
Keene, NH) using the SDS-contaning transfer buffer (50 mM Tris , 380 mM
. '
glycine , 0. 1 % SDS (wt/vol), and 20% methanol) (Harlow and Lae
, 1988).
Trasfer was cared out overnight at 300 mA at 4 C. Trasferred proteins were
cross-linked to membranes using two exposures of 0. 12 Joules of UV iradiation in
a Strtainker (Strtagene, La Jolla, CA). Membranes were incubated in 5%
dried skim milk (Blotto) (Johnson et al. 1984) and 0.2 % Tween-20 in PBS (pBS-
Tween) for 1 hour at room temperature. Blocked membraes were incubate
with the primar antibody (1:400 dilution of IgG IG or 1:100 dilution of patient
sera) for 2 hours at room temperature in Blotto-PBS-Tween, washed 3 times (10
minutes each) in the PBS- Tween, and incubated with 1: 100 dilution of 125
labeled protein- (10 uCi/ul) (Amersham, Arlington Heights, IL) in Blotto-PBS-
Tween for 2 hours at room temperature. Membranes were washed 3- 5X in PBS-
Tween for 10-15 minutes each , and exposed to Kodak X-OMAT fim.
CHAR I
INODUCTION
HIV -1 infections have different tempos and pattrns of expression in
different T-cell lines (Evans et al. , 1987; Somasunda and Robinson, 1987;
Fenyo et al. , 1988; Cloyd and Moore
, 1990; Kim et al. , 1990; Ma et al. , 1990).
mv -1 encoes regulatory as well as strctural genes. The initial goal of this
thesis was to test for the role of mv -1 regulatory gene expression in determining
different patterns of infection. The hypothesis under test was that differences in
the temporal expression of HN 1 regulatory and strctural genes would
determine differences in the kinetics of infection.
Four T-cell lines were selected for analyses. These differed in the tempo
of infection, susceptibilty to syncytium formation
, and relative surface densities of
CD4. C8166 cells were used because of their unusua susceptibilty to infection
and syncytium formation (Somasundar and Robinson, 1988). C8166 cells are a
line of Human T-cell leukemia virus typ 1- (HV-l) immortized, cord bloo
lymphocytes (Salahuddin et al. , 1983). They do not express detectable levels of
HTLV-l capsid proteins, but do express the HTV- tax gene (Giam et al. , 1986).
C8166 cells have an intermediate surface density of CD4 (Somasundaran and
Robinson , 1987; Srivastava et al. , 1991). H9 cells were studied because of their
unusual abilty to establish cells that are chronicaly producing virus (popovic et
al. 1984). H9 cells are intermediate in susceptibilty to infection
, are
intermediate in abilty to form syncytia
, and have intermediate densities of surface
CD4 (Somasunda and Robinson, 1987; Srivastava et al. , 1991). H9 cells
represent a clone of the Hut78 line which was derived from a human cutaeous
T-cell lymphoma (Gaz et al., 1980). A3.01 cells were studied because of their
high surface density of CD4 and their relative resistace to syncytium-induction
(Somasundaan and Robinson, 1987; Srivastava et al. , 1991). A3.01 cells have an
intermediate susceptibilty- to infection. They are a clone of the human
lymphoblastoid cell line CEM (Foley et al. , 1985; Folks et al. , 1985). Jurkat clone
8 cells were analyzed becuse of their abilty to undergo T-cell activation in
culture. Jurkat cells have an intermediate susceptibilty to infection, an
intermediate abilty to form syncytia, and low levels of surface CD4
(Somasundaran and Robinson, 1987; Srivastava et al. , 1991). Jurkat cells were
derived from a human leukemia cell line (Weiss, 1984).
Two laboratory strains of HIV -1 were used to analyze the role of
regulatory genes in controllng virus expression in T -cells. One of these, HIV -
II (IIIB) is a stock that has been continuously passaged in tissue culture
(popovic et al. , 1984). Most clones of IIIB are defective for one or more of the
regulatory gene products (for a compilation of these sequences, see Myers et al.
1990). The second , HIV- NI- (NI-3), is a laboratory constrct that encodes
al known HIV-l gene products (Adachi et al., 1986).
The temporal expression of HIV -1 strctura and regulatory genes was
examed using RNase protection assays. The Gag-Pol mRNA of HIV- l is
unspliced. The mRNAs for Vif, Vpr, and Vpu-Env are singly spliced and the
As for Tat, Rev, and Nef are multiply splice. Each of the splice mRNAs
create by the use of unique and speific splice sites (Sadaie et al. , 1988; Arrgo
et al., 1990; Schwar et al. , 1990a and b; Furtdo et al. , 1991; Garet, Tiley, and
Culen, 1991). These splicing patterns alowed the design of an RNase protetion
say in which one probe could distinguish the mRNAs for the regulatory gene
prooucts Tat , Rev , and Nef, as well as the bicistronic Vpu-Env mRA. This
probe could also distinguish the above mRNAs from a single fragment
representing Gag-Pol, Vif, and Vpr messages. Thus, a single probe could be used
to provide a quick and convenient screen for the mRNAs of regulatory and
strctural genes.
As expeted, the temporal analyses of mv -1 mRNAs in the T-cell lines
reveaed that the absolute amounts of all mRAs increased with the progression
of infections. However, the relative ratios of mRNAs for the strctural and
regulatory genes remained similar in the ealy and the acute phases of infection.
Furtermore, no major differences in these ratios were observed in the four T-cell
lies during the ealy and acute phases of infection. Unexpetedly, a novel
pattern of RNase protected fragments appeed in the chronic phase of H9 and
Jurkat infections. Analysis of this pattern reveaed that it was due to the selection
of varants of NI-3. Selection of these varants was speific to the chronic phase
of infection as it did not occur when virus was selecte by serial passage through
the lytic phase of infection. Chapter n wil present a detaled analysis of these
varants and their origin.
REULTS
Comparative analysis of HIV -1 inections in T-cell lies. T -cell line differ
in the teral appearane of viru-eressingcells an the ability to establish
chnic viru proders. Infections of C8166 , H9 , A3. , and Jurkat cells were
intiated with Hil and NI- at MOl of -0.25 C8166 infectious units. Since
C8166 cells are highly susceptible to HN- induce syncytia, the monoclonal
antibody leu3a was added to these cultures at 4 hours post infection to prevent
syncytium formation. The other infected cultures were grown in the absence of
leu3a.
Infections in the four T-cell lines differed in the tempora appeance 
virs-expressing cells (Figure 9). C8166 cells were highly permissive with - 20%
of the cells expressing virus , as determined by the indirect immunofluorescence
assay, withn 18 hours of infection. By 3 days post infection , more than 90% of
the cells in C8166 cultures were expressing virs. H9 , A3.01 and Jurkat cells were
less permissive with low numbers of virus-expressing cells first appeng between
one and thee days post infection. By one to two weeks post infection , 40 to 80%
of cells in these cultures became virus-expressing. In each of the infected
cultures , virus infection caused cell death. In general , a one to two day lag
ocurred between the appeance of virus-expressing cells and the appeance of
dead cells.
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Fig 9. Tempra analyse of II and NI- infecte C8166, H9 , A3. and Jurkat cells.
Inections were followed for viru-expressing cells and dea cells. C8166 cells were grown in the
presnce of 240 ng of leu3a per ml to prevent syncytium formtion. % IF A( +), 0; % dea, e.
The four T-cell lines also differed in the abilty to establish chronic virus
prOduCers (Figure 9). C8166 
cells did not establish chronic virs producers as
thes cells did not survive the lytic phase. In contrast, the lytic 
phase of infection
inH9, A3.01, and Jurkat cultures was followed by the 
appece of surviving
populations of cells. In H9 and Jurkat cultures
, cells that survived the lytic phase
contaed both virs-expressing cells and non-virs-expressing cells. In A3.
cultures, cells that survived the lytic phase did not express virs. Thus
, only H9
and Jurkat cells were able to establish chronic virs producers.
HI an NL3 differ in the ability to establish chronic viru proers. The
overa pattrns for the acute phase of infection were similar for II and NI-
in each of the four T-cell lines. Both virses replicated equay well in C8166
cells. NI- appeed to replicate slightly better than ilB in H9, A3. , and
Jurkat cells. However, more pronounce differences were observed in the abilty
of II and NI- to establish chronic virs producers. Cultures that grew out
from the lytic phase of 11m infections contaned higher proportons of virs-
expressing cells than the survivors of NI- infections. In ilB infections, 90-
100% of the H9 survivors , and - 20% of the Jurkat survivors were chronic virs
producers. In contrast, in NI- infections, only 5-20% of the H9 survivors , and
-5% of the Jurkat survivors were chronic virus producers (Figure 9).
Pattern of RNA expresion in the four T -cell lies. RNase protection
assays were underten to test whether differences in patterns of expression of
" I
regulatory and strctural genes determined differences in the time courses for the
appeance of infected cells in the four T-cell lies. Assays using RNA from IIIB
infections and probes generate from subclones of pHX-2 (a molecular clone of
IIIB) did not give interpretable pattrns of protection. This may reflect the
accumulation of mutations in the III stock leading to mismatches between the
probe and viral sequences. Therefore, further protection assays were done on
infections initiated with NI- produce by pNI-3 transfected H9 cells.
RNase protection assays used a combination of single and overlapping
probes, between nt 5661 and 6343 of NI- proviral DNA. Single probes were
used to screen for the relative levels of regulatory and strctural mRNAs in
infected cultures. Three overlapping probes were then used to verify the
assignment of bands to speific mRNA speies. These distinguished: (1) mRNAs
that do not undergo splicing between nt 5661 to 6343 (mRNAs for Gag-Pol, Vif
or Vpr), (2) the Tat and Tev mRNAs that use nt 5776 as a splice acceptor and nt
604 as a donor, (3) the bicistronic Vpu-Env mRNA that utilizes the splice
acceptor at 5975 , (4) the bicistronic Rev-Nef mRNAs that utilze splice acceptors
at nt 5953 or 5959 and the donor at nt 604 , and (5) the Nef mRNA that utiizes
the splice acceptor at 5975 and the donor at 6044 (Figure 10). The predicted
sizes of fragments representing each of these mRNAs are summarze for each of
the probes in Figure lOC.
RNA exression in the early an ace phaes of i1iecton. The temporal
analysis of cellular RNAs reveaed a steady increase in the absolute amount of
I"'"
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both spliced and un spliced mRNAs as the infections progressed from the ealy to
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FJg 10. Schematic for RNas protetion asys. A) The region mappe for RNas protete
frgments, "t (7 , known splice acptor and donor site; . ,protein sta site; ! , possible loctions
of the ends of the novel RNas protete frgments. B) Overlapping probe us for protetion
assays. Numbers denote nucleotide positions in NI- provirl DNA. The probe ar designte 
boundig restriction endonuclea site; R- EcoRI-KDnI; S-S, I to I; R- EcoRI I. C)
Siz and cog potentials of the mRA(s) represnte by expete frgments. * , an expete
frgmnt tht was not observed, D) Siz and potetial positions of novel protete frgmts,
Doublets or triplets of novel frgments with the differet siz classe are indicate by presnting
schematics in duplicate or triplicate. 
. ..
, approxite boundaes of novel frgments.
the acute phase. However, the protetion analyses did not revea 
tempora
changes in the relative proportons of regulatory and 
strctura mRNAs (Figure
11). The fragment representing Gag-Pol, Vif, and Vpr as well as fragments
representing Tat, Vpu-Env and Nef were present at the ealiest time points
analyze in each of the cell lines.
A high background of non-speific bands was detete in each of the
saples from the acute phase of infection. This may reflect the degradation of
cellular RNAs during the lytic phase of HIV- l infections (Agy, 1990).
A novel paern of RNase protected fragmnt in chronic viru proders. 
novel pattern of protected fragments came to dominate the pattern of protete
fragments as chronic virus producers emerged in H9 and Jurkat cultures (Figure
, pattern C). The novel fragments appeed ealier in H9 cultures (between 
and 28 days) than in Jurkat cultures (between 36 and 64 days) (Table 1). Once
the novel pattern appeed, it was stably present for more than two months (see
64 day point for H9 cells in Figure 11). The novel pattern appeed in each of 10
infections initiated by virus recovered from different transfections of one
preparation of pNI-3 DNA (pNI- DNA-l) (Table 1).
Mapping of the novel RNase sensitive sites in chronic vir producers.
The ends of the novel protected fragments were mappe to three approximate
positions within the NI- genome: - nt 5945, - nt 6070 , and - nt 6233 (Figure
lOD). An example of this mapping using the S-S and R-K probes is presented in
Figure 12. The novel - 410 nt fragment detected with the S-S probe correlates
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Fig 11. RNas protetion analyse of RNAs from timed infections of NI-3. Mapping was done
with the S-S probe. Designtions at the tops of autoraographs indicate the cultu and the time
aftr inection of the RNA being anyze. Designtions at the bottm of the lanes denote whether
the frgment siz are charateristic of the early and lytic (A) or chronic (C) pha of infection.
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Table 1: Occurrence of Novel Protectd Fragments
in Chronic Virus Producers
NL-3 Stock Cultures with Novel Pattern
Jurkat
Trasfection 1 (DNA- DA Y 20 (C2)*
Trasfection 2 (DNA- DAY 18 (C6) DAY 36 (C4)
DAY 23 (C3) DAY 36 (C5)
DAY 24 (ClO) DAY 64 (C9)
DAY 27 (C7)
DAY 28 (Cl)
DAY 31 (C8)
* Designation of variant viru in culture medium
Day refers to the time point (pst infection) the novel pattern was first observed
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Fi 12. Mapping of expete and novel RNas protete fragments using the S-S and R-
probe. RNas protetion data for RNA from one acute (A) and two independently established
chrnic (Cl and C2) culture of NIA-3 inecte H9 cells are presnte. The probe us for the
analyse ar indicate below the lanes, The siz and the coing potentials of the protete spies
ar indicate along the sides.
with an - 80 nt shorter fragment (- 330 nt) deteted with the R-K probe. As the
S probe would protet - 82 nt of RNA 5' to the R- K probe, the 5' end of this
fragment is positioned at the 5' end of the S-S probe. This places the 3' end of
the - 410 nt fragment at - nt 6070 of provir DNA. Similarly the - 84/80 nt
fragments detecte with the S-S probe correlate with the - 274/270 fragments
protected by the R-K probe. As the - 84/80 and - 274/270 fragments differ by
190nt and the R-K probe extends 190 nt 3' to the S- S probe, the 3' end of these
fragments is positioned at the 3' end of the R-K probe and the 5' end at -nt 6070
of proviral DNA. The - 123/124/127 cluster of fragments which lie within each
of the teste probes was positioned between - nt 5945 and - 6070, becuse the
length of these fragments was the same as the distace between the novel
sensitive sites at positions - 5945 and - 6070. The novel - 110 nt fragment was
detected only with the R-K probe and was therefore positioned at the unique end
of the R-K probe.
Analysis for size clas of RNAs. HIV -1 expresses three major size classes
of mRNAs: 9.2 kb unspliced, 4-5 kb singly spliced, and - 2kb multiply spliced.
To determine if the appeance of the novel protected fragments was associated
with the appeance of a new size class of HIV-I messages, cellular RNAs from
the acute and chronic phases of infection were analyzed by nortern blotting
(Figure 13). Membranes were hybridized with a 675 nt antisense RNA for
sequences common to all HIV- mRNAs (extending from the XhoI site in nef to a
SacI site in the 3' LTR). No new size class or shift in the proportons of mRNAs
A1 A2 A3
% 2kb: 55% 70% 56%
5 6 7
"r' 
- 9.6 kb
- 2.0 kb ..185
C1 C2 C3
61%54%52%
Fig 13. Nortern blot anysis of RNAs from cultures with the acute (A) and chronic (C) pattern
of RNas protete frgments. Laes: 1, unecte H9 cells; 2-4, RNAs from thee independently
established acute inections; 5-7, RNAs from the same culture as in lanes 2-4 aftr their conversion
to the novel pattern of protete frgments. The siz of RNA spies and the loctions of rRNAs
ar prente on the sides. The % of virl RNA presnt as 2 kb mRA (determed using a
Betape, Waltham, MA) is indicate at the bottom of lanes. See text for probe.
in the thee size classes of mRNAs were observed.
The novel RNase sensitive sites are not selected on serial pasage of Nl3
through the lytic phas of inection. To test whether the novel pattern of
proteted fragments was speific to selective pressures in chronic virs producers
a stock harested from pNL- DNA-l was selecte by serial passage through the
lytic phase of infection in H9 cells. Five serial passages were initiate with 1:10
dilutions of serial virus stocks harested from the pe or just past the pe of the
lytic phase of infection (Figures 9 and 14). The first three passages were
continued into the chronic phase of infection. Cells were harested from the
acute (A) and chronic (C) phases of each serial passage (Figure 14). Cellular
RNAs from these phases were analyzed for the RNase sensitive sites characteristic
of chronic virs producers.
Analysis of RNAs from the acute phase of the serial passages reveaed that
the novel protection pattern did not emerge on selection through the lytic phase
of infection (Figure 15 , panel A). These RNA samples , from the acute phases of
the serial passages , displayed the expeted pattern of protected fragments (se
lanes AI, All, AlI , and AIV in Figure 15A). However, when each passage was
followed into the chronic phase of infection , the novel pattern of protecte
fragments appeed (see lanes CI and CIll in Figure 15A). These results
demonstrate that selective pressures present in the chronic phase of NL-
infection are different from the pressures present in the lytic phase of infection.
Passage of pNL- DNA-l through the lytic phase of infection in the A3.
( pNL4-3-DNA- 1 J NL4-3 viral stock
DAY 6
Time in
C I
CII
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DAY::20
culture 
Figu 14. Schematic reprenting the protocl for selection of NL4- DNA-l though the lytic
phas of infection. AI-A V represnt the five serial passages though the acute phas of infection of
DNA-I. CI-CII represnt the passage of thee of the serial infections though the chronic phas of
inection.
cells also did not select for the novel RNase protected fragments (see lanes AI
All, AID and A V in Figure 15B). Beause A3.0l cells do not support the
establishment of chronic virus producers, serial passages of these infections could
not be followed into the chronic phase of virs production.
The novel RNase sensitive sites represnt the emergence of variant vir.
Selection of the novel pattern of proteted fragments in chronic virs producers
could have resulted either from the use of novel splice sites or from the selection
of speific mutations in the genomic RNA. To distinguish between these two
possibilties, viral RNA (which is un spliced) was tested for the presence of novel
sites. For these analyses , cellular and viral RNAs were harested from H9
cultures infected with (i) unselected NI-3 (NI- recovered from pNI- DNA-
transfected H9 cells), (ii) NI- that had been selected in H9 cells by serial
passages through the lytic phase of infection (lytic selection), and (Hi) NI- that
had been selected through the chronic phase of infection (chronic selection).
RNase protection analysis of the viral RNAs harested from infections that
had been selected for chronic virus production reveaed the same novel fragments
in virion and cellular RNAs (Figure 16 , panel (Hi)). The presence of these
fragments in viron RNA suggested that the novel RNase sensitive sites
represented the selection of mutations in genomic RNA rather than the use of
novel splice sites.
By contrast, NI- 3 that had undergone lytic selection had the sae pattern
of proteted fragments as un selected NI- (Figure 16, panels (i) and (ii)).
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Protetion assays of the cellular RNAs from cultures infected with both the
lytca1y selected virs and the un selecte virus reveaed the expeted pattrn of
protected fragments. These represente full length Gag-Pol, singly splice Vpu-
Env , and multiply spliced Tat and Nef mRAs. Protection assays of the virion
RNAs produced by these cultures reveaed the single, unsplice fragment
charcteristic of full length genomic RNA with no mismatches between the probe
and the genome.
DISCUSSION
The studies presented in this chapter on the tempora expression of HI-
regulatory and strctural genes in infected cells reveaed several fmdings. First
they suggeste that tempora differences in NI- regulatory and strctura gene
expression do not determine differences in the kinetics of HI - 1 expression in T-
cells. Second , they showed that cytopathc HIV - 1 strains differ in their abilty to
establish chronic virus producers. Third , they again demonstrated that T-cell lines
differ in their abilty to establish chronic virus producers. And fourth , they
reveaed that selection pressures in the chronic phase of HIV - 1 infection differ
from selection pressures in the lytic phase of infection.
Temporal expresion of structural and regulatory genes. Differences in the
temporal expression of regulatory and strctural genes did not determine the 2-
day differences in the time course of appeance of virus expressing cells. The
-- 
usage of signature splice sites for regulatory and strctura genes was simil
durig the different ' stages of infection and in each of the infected T-cell lines
(Figure 11). Kim et al. , 1989 reprt tempora differences in the expression of
the size classes of mRNAs representig the 9.2 kb , the 4-5 kb , and the 
- 2 kb
mRAs. This tempora difference occurred between 12-16 hours post infection of
H9 cells. The fact that our assays did not detect this tempora difference may
have been due to our haresting the first sample at ::18 hours post infection. By
this time, irrespetive of the tempo of infection , bands representig strctural and
, .
iJ,
regulatory genes were present at the sae relative ratios as in fully infected
.
cultures. We did not look ealier because we were interested in the role of gene
expression in determining differences in infection that were most clealy displayed
between 1 and 3 days post infection (Figure 9).
Relative usage of splice sites by HI-l. The splice site usage that we
observed was lie that previously reported for IIIb , HIV- BA- , and HI-
BRU. The splice acceptors for Nef and the bicistronic Vpu-Env mRNAs were
more efficient than the accptor for Tat and Tev or the acceptors for Rev
(Figures 11 and 13) (Guatell et al. , 1990; Robert-Guroff et al. , 1990; KIotman et
al. , 1991).
Our assay was not sensitive enough to discriminate between the relative
efficiencies of the use of the Tat/Tev and Rev acceptors as we did not detect
fragments representing Rev mRNAs (Figures lOA , 11 and 12). Our failure to
detect Rev mRNA most likely represents these relatively lowabundance messages
being represented by two fragments (91 and 84 nt), each of which would be
expeted to contan a 3 fold lower level of radioactivity than a single TatlTev
fragment (268 nt). The high intensity of the fragment representig unsplice Gag-
' ,
" l Pol as well as singly splice Vif and Vpr mRAs as oppose to multiply splice
mRAs in the protection assays reflects (1) the presence of fragments
representing multiple mRNAs in one band and (2) the intensity of fragments
being directly related to their length.
Entry is the major determant of diferent kietics of expresion in T-
cell. Our results revea that differences in the expression of the regulatory genes
of mv -1 were not the major determinant of the different kietics of infection
observed in the four T-cell lines. Subsequent work in our and other laboratories
has shown that the major determinant of permissiveness of cell lines occur at the
level of virs entr (Km et al. , 1990; Srivastava et al. , 1991). These studies
showed no major differences in the timings of reverse trscription, use of the
long terminal repet, expression of viral RNA or proteins, and production of virus
parcles once entr had taen place. Single cycle infections of C8166 , H9 , A3.
and Jurkat cells with NL-3 reveaed that the time neeed for viral entr into the
cells was 30 minutes for the most permissive C8166 cells , 4 hours for the less
permissive H9 and A3.01 cells, and 5 hours for the least permissive Jurkat cells.
All four cell lines required about 3.5 hours for reverse transcription. The time
required for the expression of viral antigens was somewhat varable with C8166
requiring an average of 17 hours , H9 cells requiring 22 hours , and A3.01 and
Jurkat cells requirig 25 hours (Srivastava et al. , 1991). Thus, the biggest
difference (eight folds) in the times required for steps in the virs life cycle
occured at the entr step.
Differences in the abilty of cytopathic HI -1 isolates to esblih chronic
vir producers. Our data demonstrte that Nl- 3 and IIm have different
cytopathic effects and substatially different abilties to establish chronic virus
producers (Figure 9). The low abilty of Nl- to establish chronic virus
producers is similar to what we have observed for two PBL-passaged patient
isolates, SF94 and SF216 (Cheng-Mayer et al. , 1988; York Higgins et al., 1990).
These virses undergo lytic as well as chronic phases of infection on H9 cells.
Only 10 to 20% of the survivors become chronic virus producers (Robinson and
Zins. , 1991). Thus , the high abilty of IIIB and a clone of IIIB , HXB-2 (see
Chapter II), to establish chronic virus producers may be relatively unique to II,
a laboratory str that was heavily selecte for the abilty to establish
contiuously producing cultures (popovic et al. , 1984).
Differences in the abilty of T -cell lies to esblih chronic vir
producers. Only two of the four tested T-cell lines (H9 and Jurkat) generated
easily detected levels of chronic virus producers (Figure 9). Of these two , H9
cells underwent both more rapid and efficient generation of chronic virs
producers. The differentiated state of H9 and Jurkat cells is distinct from that of
C8166 and A3.01 cells in displaying the T-cell recptor (TCR) and CD3
(Srivastava and Robinson, 1990). Both of these T-cell markers interact with CD4
durig T-cell activation (for reviews se Bierer et al. , 1989; Robey and Axel
1990). Whether a differentiated state that is charcterize by these markers or
other host cell factors influence the efficiency of the establishment of chronic
infections remains to be determined.
Differences in selective presres in the lytic and the chronic phas of
inection. Passage of virus recovered from Nl- DNA-1 through the chronic
phase of infection resulted in the emergence of viral varants. By contrast, serial
passage of virus recovered from Nl- DNA-1 through the lytic phase of infection
did not select for the varants that emerged in the chronic phase of infection
(Figures 15 and 16). This demonstrates that different selection pressures exist in
the acute and chronic phases of HIV -1 infection. These two phases of infection
differ from each other in several ways. Cultures from the acute phase of infection
conta both CD4( +) and CD4( -) cells. During this phase, virus is undergoing
spread and high titer production. Infected cells may die either by syncytium
formation or as mononuclea cells.
In contrast, cells that become chronic virus producers produce lower levels
of virus and remain heathy. These cells have down regulated CD4 from their cell
surfaces. Preliminar data indicate that cells in the chronic phase may express
increased levels of several cell surface markers that are involved in T-cell
activation and cell-to-cell communication. These include the T-cell receptor
CD3 , and CD45 (data not shown). In contrast, surface density of the CD3
antigen on acutely infected H9 cells has been reported to remain the same as on
-- --
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uninfecte cells (Meerloo et al. , 1992). What the involvement may be of the T-
cell markers, if any, in the establishment of chronic virus producers remains to be
determned (se Summar and Future Directions).
CHAPTER 
INODUCTION
Work presented in Chapter I demonstrte the selection of NI- varants
in the chronic phase of infection of T -cells. These varants were not selecte
when virs was serially passaged through the lytic phase of infection. The goal of
the studies presented in this chapter was to characterize these varants and to
establish their origin.
Temporal analyses of H9 cultures infecte with the varants reveaed that
the varants had high abilty to establish chronic virus producers. Paral cloning
and sequencing of the varants reveaed that they contaned HXB- like mutations
in tat and vpu. These mutations were not sufficient, by themselves
, to increase the
abilty of NI- to establish chronic virus producers. Thus , despite the fact that
mutations in tat and vpu were selected in chronic virus producers, other mutations
with the HN 1 genome are essential to the efficient establishment of chronic
virs producers.
REULTS
Characteriation of variant virses: 
Temral ansis of H9 cures i1iected with
the varian. The varants that emerged in the chronic virus producers were
present in 10-30% of the initially infected cells. The de novo abilty of these
varants to establish chronic virus producers was tested by infectig fresh H9 cells
with these varants. The infections were initiate at an equal MOl (0. 1 infectious
units per cell) with NI- 3 and two of the varants. These varants had been
independently selecte in chronic H9 (N- Cl) or chronic Jurkat (N- C4)
cultures (Table 1). Infections were followed with time for cell growth , virs-
expressing cells, and cell death (Figure 17, panels A-C). Both of the varants were
much more effective at establishig chronic virs producers than the unselecte
NI- stock (Figures 17 and 18). In addition, cultures infected with the varants
grew much better and had lower cell death durig the acute phase of infection
than NI- infected culture (Figure 17, panels A and B). Thus , the varants that
had evolved in the chronic phase of infection had a much higher abilty to
establish chronic virs producers and a lower cytopathic potential than the
parenta NI- virus.
Prteins exression by the varans. To compare protein expression by the
varants with that of NI- protein extracts were prepared from NI- , NI-
Cl- NI- C2- and NI- C9-infected H9 cells (for origin of the varants, se
Table 1). Proteins extracts were also prepared from NI- Cl virions. Figure 19
presents the immunoprecipitation and western analysis of these proteins. 
poled patient sera (IgG-IG) was used for all immunoprecipitations. No apparent
differences were observed in the expression of p55 , gp41 , p24 , or p17 (Figure 19)
and gp120 (data not shown) among the different viruses. However, this analysis
did not preclude differences in proteins not recognized by the IgG-IG sera.
Clning an sequncng of the varians. To evaluate the genetic basis for
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Figur 17. Tempra analysis of NI- NI- Cl- (Cl), and NI- C4- (C4) inected H9 culture.A) Growt of inecte cultures; B) tempra apperace of vir-expressing cells; C) tempraappce of dea cells. Inections were intiate with an MOl of 0. 1 inectious unts per cell. 
and C4 reprent independently selecte varants in chrnic H9 and Jurkat cells, retively.
, ,
, I
Fige 18. Photomicrogrphs of the cultures in Figure 17 at 19 days post infection,
Imunofluorent sta is for mV-1 antigen. A) unfecte; B) NU- infecte; C) NIA- C1-
inecte; D) NU- C4-inecte H9 cells.
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69K-
45K - 
30K-
21K-
14K-
p55
gp41
p24
p17
Figur 19. Protein expression by the varant viru. Immunoprecipitation and western anysis of1l- spific protein expresse by 1) unfected H9 cells and by H9 cells infecte with 2) Nl-
3) Nl- C9; 4) Nl- 5) Nl- C1 virons; and 6) Nl- C2. A poled patient sera, IG-G,
was us for the immunoprecipitations. Designations along the sides indicate the Il - spific
protein observed and the siz of the molecular weight markers.
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the novel RNase sensitive sites that had appeed in the varants, the region
contaning the novel sites was cloned and seuence. To accmplish this
sequences encompassing a 60 bp EcoRI to KpnI fragment were reverse
transcribed PCR amplified and subcloned (nt 5743 to nt 6343) (Figure 20). Sub-
cloning was done into pNI-3 so that the biologica significace of the encoded
mutations could be tested in a NI- background (se Figure 8 in Materials and
Methods for the cloning strategy). This analysis was done for three viruses that
had been independently selected through the chronic phase of infection (N-
, C2 , and C4) (Table 1), and two virses that had been independently selecte
by passage through the lytic phase of infection (N- , and L2). Two to three
subclones of PCR-amplified products were sequence for each of the selecte
virses (Figure 21).
Spedfic nuleoti chages co-ma with the RNase senstive sites in the
varians. Sequence analyses of the amplified regions reveaed the presence of
speific nucleotide changes at each of the novel RNase sensitive sites. Some of
the fragments from each of the viruses that had undergone selection in the
chronic phase contaned mutations that co-mappe with the novel RNase sensitive
sites (Figures 10 and 21). By contrst, none of the fragments from the virus that
had undergone lytic selection contaned mutations. S out of the 9 clones from
the virses that had undergone chronic selection contaned base changes that co-
mappe with the RNase sensitive sites tentatively mappe to positions 5945 (site
1) and 6070 (site 2) (Figures 10 and 21). Three out of the 6 contaned mutations
vpr
tat, tev
I env 
vpu
5776
Novel RNase
Sensitive Sites
Known Splice Sites
Eco Kpn I
Sequences of the primers and oligos are
as follows:
RI (+) 5' GCCATAATAAGAATTCTGCAACAACTGC 3' (5733- 5760)
RI (-) 5' GCAGTTGTTGCAGAATTCTTATTATGGC 3' (5760-5733)
Kpn (+) 5' GTCTATTATGGGGTACCTGTGTGGAAGG 3' (6332-6359)
Kpn (-) 5' CCTTCCACACAGGTACCCCATAATAGAC 3' (6359-6332)
(-)
5' CAATAGCAATTGGTACAAGC 3' (5909-5890)
5' TACTGCTIGATAGAGAAGC 3' (6047-6028)
5' ATGATTACTATGGACCACAC 3' (6140-6121)
Figur 20. PCR amlification strategy. The 600 bp of the variant viru analyze in the protetion
assays was PCR amlified using the EcoRI and KonI primers. Aftr digestion of the amlified
products with the appropriate restriction enzmes, the products were subcloned into pNI-3 (se
Figue 8). The subclones were seuence using the a, b, and c as well as the EcoRI and KpnI anti-
sens oligonucleotides.
SITE SITE SITE
5946 5960 5976 6026 6061 6072 6238 6270 6295 6311
NL4- TGA ATGC A... A GAAGT
HXB2 taa acgc accaa gaaat
C1b -c-- -cca -
C1c -a- c-- -cca -
C1h -a- -c-- -cca-
-----
C2d
-----
C2r -c-- -cca-
g-
C2s
C4"
 
-a- c-- -cca- ---a-
C4u -a- c-- -cca- ---a-
L1b
L1p
-- --
L2d
L2f
FIg 21. Schematic demonstrating the co-mapping of seuence changes with novel RNas
sensitive site. Positions in pNL4-3 DNA are given at the top. NL4-3 seuence are prente 
capita letters, HXB-2 seuence are presnte in lower ca letters with difference between NL4-
and HX-2 being presnted in bold typ. Sequence data for independently selecte chronic (C) and
lytic (L) stocks are presnte. Subclones of each stock are groupe and indicate in lower 
letters (e.g. Clb, Clc, and Clh for NI- CI). Sequence tht differ from NI- in the selecte
vir are indicate in lower ca lettrs with those that are HXB- like being shown in bold. -, nt
identical to that in NI-3; , an insertion, .." seuence presnt in HXB-2 but not in NI-
- - - - -
co-mapping with the third RNase sensitive site (psition 6233 , Figures 10 and 21).
The mutations observed at each site were analyze for the ty and
frequency of change. Al of the 6 mutations at site 1 represente the sae
change (a transition from G to A). Mutations at site 2 included identica multiple
changes in a 10 bp region (a transition from T to C and inserton of a CCA
coon). In contrast to sites 1 and 2 , site 3 contaed different mutations that were
less heavily selected. Two different mutations were present in the three clones
with site 3 mutations (either a transition from A to G at nt 6236 or a trsition
from G to A at nt 6238). Mutations that did not co-map with RNase sensitive
sites did not appe to undergo uniform selection. These were unique to clones
from independent varants. In agreement with RNase protection assays, none of
the 4 clones from virs that had undergone lytic selection contaned base changes.
These data suggest that mutations at the RNase sensitive sites appeed 
represent the selection of speific mutations in NI- 3 in chronic virus producers.
Th varian are decient in the exression of Vpu. A site by site analysis of
the mutations in the PCR amplified regions of the varant viruses reveaed that
most either changed or did not affect codons in the tat, rev and env genes (Table
2). However , mutations in vpu had a more pronounced effect on protein
expression with the changes in vpu abrogatig Vpu expression by the replacement
of the initiator methionine with a threonine.
The absence of Vpu expression in the varants was verified using
immunoprecipitation of 1abeled cells. H9 cells infected with NI-3, NI-
Table 2: Amino Acid Changes Encoded by Mutations
Position (Site)
in the Variant Viruses
----------------------------------------------------------------------------------------------
Amino Acid Change Protein Mutation Type
5946 (Site 1)
5960
5976
6026
6062 (Site 2)
6072 (Site 2)
6239 (Site 3)
6241 (Site 3)
6270
6311
Intiator AUO
Insertion of a codon
M -- 
Tat Sense
G -- Tat Sense
R -- Tat Wobble
G -- Rev Sense
Q -- Tat Sense
K -- Rev Sense
M - Vpu iAUG
knockout*
p**
Vpu Inserton
K -- Env Sense
K -- Env Wobble
K -- Env Sense
A -- 
Env Sense
200K -
97K-
69K-
45K-
30K-
21K-
14K- 
+-Vpu
Figur 22. Immunoprecipitations of 3S labeled protein extrats to tet for the presnce of Vpu in
cultures infecte with varant vir. Laes: 1) unfecte; 2) NL4- ; 3) NL- C1- ; 4) NL4- C4-
and 5) HX- inecte cells. For experienta detas, se text. Designations along the sides
indicate the siz of the molecular weight makers us.
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NI- and HX-2 (a virs known to be defective for the expression of vpu)
were metabolicaly labeled with 35S-methionine and 35S-cysteine for 4 hours.
Protein extracts were prepared in the RI A buffer and analyze for the
expressio of vpu by immunoprecipitation with an anti- Vpu sera. As sen in
Figure 22 , only NI- infecte cultures contaed the Vpu protein. The other
vises were deficient in the expression of vpu, as predicte by the seuence
analysis (Figure 21).
Nuleoti chages rejct the selecton of HX- like sequnces. The
changes in the mutat sequences were compared with mutations in other mV-
seuences to lea more about-eir relationship to other laboratory strns and
naturally occurrg isolates (Myers et al. , 1990). This comparson reveaed that
most of the mutations represented differences in the sequences of NI- and
HX-2 (Figure 21). In parcular, the CCA inserton at site 2 is charcteristic of
HX-2. HX-2 is a molecular clone from the TIm/LA family of viruses with a
high abilty to generate chronic virus producers. This suggested that the
mutations might have arsen from recombination of pNI- DNA-l with a low
level of contaminating pHXB-2 DNA.
Origin of the variant vires. To test whether the varant virses emerged
as a result of de novo generation and selection of mutations or to contamination
of pNI- DNA- l with pHX-2 DNA , an independent preparation of pNI-
DNA was tested for the generation of the varant virses. In addition , RNA
isolated from the acute phase of infection of pHXB- transfected cells was
analYze for the novel pattern of 
protected frgments.
A single colony of pNI- transformed bacteria was 
use to produce
pl"- DNA-2 (DNA-2). Virus produce from DNA-
2 was passaged through the
chronic phase of infection (till day 41) in H9 cells and 
analyze for the generation
of the novel RNase sensitive sites. The novel 
sites did not emerge in chronic
producers of virus recvered from ths DNA (Figure 23A). Ths 
is in contrast
with a parallel infection initiated with a stock from DNA-
I. The novel RNase
sensitive sites were apparent in this culture by day 24 (Figure 23A).
The RNase protection analysis of RNA harested from pHXB-
transfected
cells reveaed the same novel pattern of protecte 
fragments as observed in the
chronic virus producers of pNI- DNA- transfected cells (Figure 23B). 
These
results suggest that the varants observed in infections initiate with 
pNI- 3-
DNA-l might have reflected the selection of speific regions of a 
contaminating
HX-2 genome.
The 600 bp tes region of the variants is not sufficient to change the 
abilty
of NI3 to establih chronic vir producers. Sequence analysis of the 60 bp
test region of the varant viruses had reveaed that only certn sequences from
the HXB-2 genome had been selected in the chronic phase of infection.
Therefore, it was of interest to test if the 600 bp region of the varants, sub-cloned
into pNI-3, could alter the abilty of NI- to establish chronic virus producers.
To test for this possibilty, recmbinant 
NI- clones contaning the 600 bp region
were transfected into H9 cells along with pNI-3 and pHXB-2 DNAs. Two 
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Fig 23. Analysis of pNl- DNA-2- and pHX- trasfecte H9 cultures for the generation of
the novel pattrn of protete frgments. A) RNas protetion analysis of RNAs harveste from
pNl- DNA-2- and pNU- DNA- trafecte cultures at day 41 post trafection. The S-S probe
was us for ths anysis; B) RNas protetion analysis of RNAs harveste from several time points
of HX-2-trasfecte H9 cultues. The R-K probe was us for ths anlysis. The panel on the
right shows the tyical RNas protetion pattrn obtaed with the R-K probe. The siz and cog
potentials of the protete speies are indicate along the sides,
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the recombinant clones , pChl and pC2r, represente subclones of varants that
had arsen in independently trsfecte H9 cells, whie pC4t represente a
subclone from the varants originatig in the Jurkat cells. The cultures were
followed for virus-expressing cells , cell growth, and cell death (Figure 24).
Results of the temporal analysis of cultures transfected with these DNAs
showed that the 60 bp region containg the HX- lie sequences did not
increase the abilty of NI- to generate chronic virus producers (Figure 24A).
C2r had a low abilty to generate chronic virus producers. It was NI- like in its
abilty to establish chronic virs producers. Clh was somewhat better than 
NI-
in its abilty to generate chronic virus producers. No expression was observed for
the pC4t clone. Cultures transfected with C Ih and C2r grew slightly better than
NI- transfected cultures (Figure 24B) and had intermediate levels of cell death
(Figure 24C). Thus, the 600 bp region had some effects on the growth of these
cultures , but was not sufficient, by itself, to make NI- an efficient chronic virus
producer.
DISCUSSION
Characterization of the varant viruses that emerged in the chronic phase
of infection of H9 cells and Jurkat cells reveaed that the varants contaned
HXB- like mutations in the tat and vpu genes. However, only certn HXB-
sequences were present in the 60 bp region that was analyze for mutations with
VIRUS EXPRESSING CELLS
100
NL4-
HXB-
---0--- pC1h
---0-- pC2r
CELL GROWTH
H9C
NL4-
---.--
HXB-
---0--- pC1h
---0-- pC2r
CELL DEATH
100
NL4-
HXB-
- 20 ---0--- pC1h
---0-- pC2r
Days post infection
Fi 24. Tempral anysis of NIA- , HXB- , pClh-, pC2r-, and pC4t-trafecte H9 cultures.
A) Tempra appece of viru-expressing cells B) growt of infecte cultures C) tempra
appece of dead cells. pC4t did not give any expresion. H9C, unfecte H9 cells.
the remaider being NI- like. Biologica test of NI- recombinants with the
selected HX- lie mutations demonstrate that these mutations were not
sufficient for the establishment of chronic virs producers. Thus , the abilty to
establish chronic virus producers requires seuences other than (or in addition to)
the 60 bp region that had been analyze for mutations.
Selection of certin HX2-lie mutations in chronic vir producers.
Sequence analysis of three independently derived varants in the region contaning
the novel RNase sensitive sites reveaed that the varants contaed sequences
common to both NI- and HXB-2. This common region (from position 5780 to
position 5945 of proviral DNA) was followed by sequences characteristic of HXB-
2. In two of the varants , HXB- like sequences were found between position
5946 and 6073. In the . third , they were present from 5946 to 6270. Therear
sequences were agai characteristic of NI-3. Other changes (found in neither
NI- and HXB-2) were scattered and not common to independently generated
varants. Presumably these reflected polymerase errors that had occurred in the
infected cell or during reverse transcription and PCR amplification. Taq
polymerase has no 3' 5' exonuclease activity and has a strong bias for T --- 
transitions (Tindall and Kunkel , 1988), while the mV- l reverse transcriptase is
prone to GpA dinucleotide transitions (see below) (Varian et al. , 1991).
HXB- like mutations that were selected at RNase sensitive sites 1 and 2
introduced coding changes into the viral genome. The selected mutation at
RNase sensitive site 1 changed the 39th amino acid of Tat from a methionine to
isoleucine. This position in Tat vares in different isolates of 
HI -1 with
, isOleucine or threonine being present in - 
80% of the isolates in the Los Alamos
ta base (Myers et al. , 1990). Amino acid position 39 is contaned within Region
Uof Tat, one of the two trans-activation domains of the protein 
(Garcia et al.
1988; Green et al., 1988). Ths mutation in tat does not seem to affect the abilty
of NI-3 to establish chronic virs producers (se pChl and pCr2 in Figure 24A).
The mutations at RNase sensitive site 2 changed the initiator methionine
for Vpu to a threonine. Analysis of the proteins expressed by the varants
reveaed that the varants were deficient for Vpu (Figure 22). Biologica analysis
of the recombinant NI- viruses encoding the vpu mutation showed that the
absence of Vpu did not favor the establishment of chronic virus producers (Figure
24A). The inabilty of vpu mutats to generate higher levels of chronic virus
producers is not surprising since vpu mutats of 
NI- are, at least as cytopathic
as the NI- parent (Strebel, Klimkat, Marn, 1988; Cohen et al., 1988). Our
recombinant NI- viruses contaning the HXB- like vpu mutation were
somewhat less cytopathic than the parenta NI- (Figure 24C). This may reflect
the presence of the additional HXB- like tat mutation at amino acid 39 (Table
2).
Mutations at RNase sensitive site 3 underwent less strong selection than
those at sites 1 and 2. This had been noted in the RNase protection assays where
the intensity of novel bands representing site 3 vared among independently
selected varants (data not shown). The nucleotide change that marks this site in
HX-2 is silent. Thus, this site , which is within 177 bp to the more highly
. selecte mutations at site 2 , may be incidenta to the recombination events that
generate the varants.
Selection for specifc mutations in imunodeficiency vir in tise
culture. Precedence for the efficient selection of speific varants of an
immunodeficiency virus is found in work on simian immunodeficiency virus
macaque (SIV maJ where trncated forms of the transmembrane protein, TM
were strongly selected for or agaist depending on whether SIV mac251 was cultured
in non-permissive (human) or permissive (monkey) PBLSs (Kodama et al. , 1989).
Ths selection took place in the fIrst 20-30 days of culture with selected mutations
being stable during subsequent culture.
Frequent transitions of G to A in HIV -1 genomes undergoing pasge in
tise culture. Of the eight positions within the 60 bp region showing nucleotide
chages (excluding the CCA inserton) seven of the changes involved a transition
between the G and A bases (Figure 21). Of these five involved G to A
trsitions. Four of the eight positions contang transitions were non-HXB-
lie. Such frequent transitions between G to A have been observed in tissue
culture-passaged HIV-l isolates. Varatian et al. , 1991 have shown that multiple
passages of HIV- B40 on peripheral bloo mononuclea cells results in extensive
G to A mutations. These have been called "hyprmutations" due to their frequent
occurrence. Such mutations are apparently the result of disloction of the primer
with respet to the template during reverse transcription of the viral genome by
"",,
the viron-associated reverse transcriptase.
Origin of HXB-2-lie sequences. Results presente in ths chapter suggest
that the varant viruses that had emerged in the chronic virs producers could
have originated as a result of recombination of NI- with low levels of
containatig HX-2 sequences (Figure 23). Recombination between retrovira
genomes is a well known phenomenon (Coffin , 1979). Clavel et al., 1989 have
studied HI -1 recombination in cells harboring two defective HI -1 genomes.
Their results suggest that phenotypically complete, heterozygous virions are the
intermediate in the recombination process with the actual recombination tang
place in the next round of replication.
Based on these observations, we could hypthesize on the likely scenaro
responsible for the generation of the varants. Possible co-transfection or
infection of the same cell with two viral genomes (primarly NI- and only
occasionaly HXB-2) could have resulted in the co-packaging of heterozygous
RNA templates. Once these heterozygotic virions had infected fresh cells
recombination could occur during reverse transcription of the co-packaged
genomes. The apparent selection of very short HXB-2 regions in the 600 bp 
fragment suggests that multiple recombination events took place between NI-
HXB-2 recombinants and NI-
The region encodig the HXB- lie tat and vpu mutations is not sufficient
for the efficient establihment of chronic virs producers. The factors that allow
a virs to generate chronic virus producers are not understoo. Selection of
speific HXB- like mutations in the chronic and not the lytic phase of infection
suggested that these mutations might be importt in the generation of chronic
virs producers (Figure 15). However, biologica tests of NU- recmbinants
with these mutations reveaed that , by themselves, the mutations were not
sufficient to convert NU- from an inefficient to an efficient chronic virus
producer (Figure 24). Thus , other mutations are importt to the establishment
of chronic virus producers. Analyses presented in the next two chapters use NU-
3 and HX-2 to map the auxilar as well as the non-auxilar gene sequences
importt in the establishment of chronic virus producers.
CHAFfER III
100
INODUCTION
The abilty of mv -1 to establish chronic virus producers is a porly
, -
understoo phenomenon. Work presented in Chapters I and II identified two
molecularly cloned virses with distict abilties to establish chronic virs
producers. One of these NI- had a low abilty to generate chronic virus
producers, whereas the second , HXB-2 had a high abilty to generate chronic virs
producers. NI- 3 is a laboratory constrct that encodes all known HIV -1 gene
products (Adachi et al., 1986). HXB-2 is a molecular clone from a stock of HIV-
IIIB that was selected for the abilty to establish chronic virs producers
(popovic et al. , 1984; Fisher et al. , 1985). HXB-2 is defective for three non-
essential auxilar genes: vpr, vpu and nef The goal of studies presented in this
chapter was to determine whether defective vpr, vpu, or nef genes could convert
NI- 3 from a virus with low abilty to establish chronic virus producers to a virs
with high abilty to establish chronic virus producers.
To elucidate the potential role of vpr, vpu, and nef genes in the
establishment of chronic virus producers , a series of NI- mutats encoding all
possible combinations of defective vpr, vpu and nef genes were constrcted. Tests
of these NI- 3 mutats reveaed that vpr and nef limit the abilty of NI- 3 to
establish chronic virus producers.
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REULTS
NI3 and HXB-2 have diinct abilties to generate chronic vir
producers. To test the relative abilties of NI- and HXB-2 to establish chronic
virs producers , exponentially growing H9 cells were transfecte with equa
amounts of either 
pNI- or pHXB-2 DNA. As expeted, the parenta virses
exhibite distinctive prof1es for the establishment of chronic virus producers
(Figure 25). 
NI- established low levels of chronic virus producers (15-20%)
whereas HXB- 2 established high levels (:; 80 %) (Figure 25A). The parenta
virses also differed in their overall effects on cell death (Figure 25C) and cell
growth (Figure 25B). HXB- trsfected cultures had relatively low levels of cell
death with the surviving cells having normal growth charcteristics, similar to
those of uninfected H9 cells. In contrast, NI- transfected cultures exhibited
more cell death and overal porer cell growth. NI- and HXB-2 transfections
also differed in that HXB- transfected cells exhibited an - 10 day lag over NI-
transfections for the appeance of infected cells (Figure 25A). This lag was not
observed if virus was used to initiate infections (data not shown). The reason for
this lag is not clea.
Tes for the effects of Vpr, Vpu, and Nef on the abilty of NI3 
esblih chronic virs producers. Table 3 lists the amino acid differences
between NI- and HXB-2. As apparent, the most prominent differences
between the two viruses occurred at the coding sequences for vpr, vpu, and nef
102
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Figur 25. Tempora analysis of pNI-3- and pHX-2-trasfecte H9 cultures. A) Temporalappece of viru expressing cells; B) growt of cultures; C) tempral presnce of dea cells.H9C, unfecte H9 cells.
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Table 3: Amino Acid Differences Between NL-3 and HX-
Protein No. of Changes Changes in HX-
Gag Sense mutations
Pol Sense mutations
Vif Sense mutations
Vpr Sense + 18aa truncation
Tat Sense mutation
Tev Sense mutations
Rev Sense mutation
Vpu Abrogation of iAUG*
Env Sense mutations
Nef Sense + 83aa truncation
* Intiator methionie
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genes. Therefore, to test for the effects of auxiliar gene differences in the
of chronic virus producers , mutats of NI- contaning all possible
combinations of defective vpr, vpu and nef genes were constrcte. These
mutats were tested for their abilty to establish chronic virus producers in H9
cells. Table 4 summarzes the constrction of these NI- mutats and compares
the defects in their vpr, vpu and nef genes with those in HXB-2. Tests for the
abilty of the mutat genomes to establish chronic virs producers were initiated
by transfecting H9 cultures with plasmid DNAs. Transfections with parenta
DNAs were cared out in parallel to allow direct comparson of the abilty of
mutat and parenta genomes to establish chronic virs producers. Trasfected
cultures were monitored over time for virs-expressing cells, cell growth and cell
death.
The NI- auxiiar gene mutats vared in their abilties to establish
chronic virs producers. Overal three patterns were observed: inefficient
establishment of chronic virs producers (Figure 26A), intermediate establishment
of chronic virs producers (Figure 26B) and efficient establishment of chronic
virs producers (Figure 26C). Two mutats, NLA U and NLA U AN, had low
abilties to generate chronic virus producers (Figure 26A). The efficiency with
which these mutats generated chronic virus producers was similar to that of the
NI- parent. Three mutats , NLAR, NLAN, and NLARAU , showed
intermediate abilties to establish chronic virus producers (Figure 26B). Cultures
infected with these viruses exhibited transient high levels of virs-expressing cells
105
Table 4: Comparison of vpr, vpu, and ne genes of
NL-3, NL3-mutats, and HX-
NL4- NL4- HXB-MUTANTS
Fil-in of EeoRI site Mutation creating a(nt 5743) creating a
Vpr 96 amino acid frame shift at amino frameshift at aminoprotein, acid 63 and a acid 71 and atruncation 7 aminotruncation 1 6 amino acids later.
acids later.
Addition of an Xho
linker at I site (nt
Loss of initiator
VPU 81 amino acid 61 53) creating a frameprotein. shift at amino acid 32 Methionine.
and a truncation 3
amino acids later.
Fil-in of the 
206 amino acid site (nt 8887) creating Mutation generatingNef protein. a frame shift at amino a stop codon after
acid 35 and a truncation amino acid 123,
11 amino acids later.
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(days 5-15 of culture). Two viruses
, the double mutat NLARAN and the trple
mutat, NLAR AU AN, had high abilties to 
generate chronic virus producers
(Figure 26C). There was no 
difference in the relative abilty of these two mutats
. to generate chronic virs producers. 
Ths suggests that defects in both vpr and nef
ar sufficient for NU- to establish high levels of chronic 
virs producers with
mutations in vpu 
not furter eIiancing ths abilty.
In general, the abilty to establish chronic virus producers 
correlated
inversely with the amount of cell death in 
cultures. This can be seen most clealy
II,
in Table 5 where mutats are listed from 
decreasing to increasing abilty to
establish chronic virus producers. The two 
NU- mutats that had a low abilty
to establish chronic virus producers (NLAU and NLAU 
AN) exhibited high levels
of cell death durig the acute phase of infection. By contrast
, the two mutats
that were efficient at generating chronic virus producers, NLARAN and
NLARAU AN, caused only low levels of cell death. 
In keeping with this trend,
cultures infected with two of the three viruses with intermediate abilty 
generate chronic virus producers (NLAR and NLAN) had 
intermediate levels of
cell death. However, the culture infected with the third virus with an
intermediate abilty to establish chronic virus producers (NARA U) had 
low levels
of dead cells. This exception indicates that low cytopathicity does not ensure the
efficient outgrowth of chronic virs producers.
The efficient establishment of chronic virus producers did not necessaly
correlate with cultures having a normal growth potential. The 
growth potential of
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Table 5: Summary of data on the NL4-3 mutants
Test Auxiliar Chronic rowt Post
Vir Vpr Vpu Nef Produc Death Transfection
NL4- I II I I
Lag
NLL\UL\N
NLL\U
NLAR
NLL\
NLLRL\U
NLARL\
NLARL\lJ.1N
HXB- IIIII I I I II I I I I I
(+), presence of; (-), absence of auxilary genes
The last four columns present the extent of the various tested phenotypes using a scale of (-) for
least effect to (+++++) for maximum effect.
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cultures was determned both by the 
amount of cell death during the acute phase
1)finfectio and by the doubling times of the surviving 
cells. Following the acute
phass of infection , the doublig times for NL N- and NL
N-expressing
cultures were slower than for uninfecte or HXB-
2-expressing cultures. These
cultues had only intermediate growth characteristics and did not exhibit the
normal growth characteristic of uninfecte 
or HXB-2-expressing H9 cells (Figure
The efficient establishment of chronic virus producers did not require the
long post-transfection lag observed in the HXB-2-transfected 
cultures. In
N- and NL N-transfected cultures, infected cells were detected
with 1 to 3 days of their appeance in NI-3-transfected cultures (Figure 26C).
The infection and growth patterns summarzed in Table 5 were highly
reproducible with similar results being obtaned in independent growth tests
(compare growth tests on NI-3- and HXB- transfecte cultures in the three
indepndent tests shown in Figures 25, 26 , and 27).
DISCUSSION
We have demonstrated that two auxilar genes vpr and nef, have the
potential to limit the abilty of HIV -1 to establish chronic virus producers. For
. NI- infections , defective vpr and nef genes were sufficient to change the
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efficiency of the establishment of chronic virs producers from low to high
(Figure 26 and Table 5). The potential function of these two auxilar genes 
limitig the abilty of 
NI- to establish chronic virs producers is discusse
below.
Roles of vpr and ne 
in the esblihment of chronic vir producers: Th
gene pros. Both vpr and nef are non-essential HIV -1 genes. Vpr is a 96
amino acid , 15 kd , virion-associated protein (Wong-Sta, Chanda, and Ghrayeb
1987; Cohen et al. , 1990a and b; Yuan et al. , 1990). It is not essential for virus
assembly. Western blots of sub-cellular fractions suggest that Vpr may be
membrane associated (Sato et al. , 1990). Multiple Vpr molecules (probably
dimers) are found in each viral parcle (Cohen et al., 1990a; Gras-Masse et al.
1990). The entie Vpr protein is importt for its function since even a three
amo acid trncation in its arginine rich caboxy terminus ca abrogate function
(Cohen et al. , 1990b; Yuan et al. , 1990). Arginine rich regions are importt 
nuclea localtion as has been demonstrated for Tat and Rev (Hauber et al.
1989; Cochrane et al. , 1990; Subramanian et al. , 1990). They are also found in
RNA binding proteins like lambda phage N protein (Linski et al. , 1989). Thus
Vpr may exert its effect by binding to genomic RNA and/or nascent viral or
cellular transcripts.
Nef is a non-virion associated , non-structural protein (reviewed 
Hovanessian, 1992). It has two protein products: p25 and p27. Most forms of p25
are N-terminal trncated forms of Nef that are produced by the use of an internal
111
methionie, 19 codons downstrea from the initiator coon (Kinchik et al.
1990 and 1991). Such forms of Nef are cytoplasmic proteins (Kaminchik et al.,
1991). A second p25 form of Nef ca result from an anomalous mobilty of
certn alleles of Nef on denaturing gels. This is seen for Nef proteins that
contan alanine instead of an asparte at position 54 (Obar, De Clue , and
Haseltie, 1992). NU-3expresses the p27 form of Nef though it contans an
alanine at position 54 (Luria, Chambers, and Berg, 1991).
The full-length p27 Nef is a myristoylated protein that is associated with
the plasma membrane (Allan et al. , 1985; Franchini et al. , 1986; Kaminchik et al.
1991). p27 Nef can down regulate the CD4 receptor for HN- from cell surfaces
of T-cells , B-cells , monocyte/macrophages, and the non-lymphoid HeLa-CD4 cells
(Guy et al., 1987; Garcia and Miler, 1991). It can also limit the abilty of
mitogenic stimuli to induce the transcription factor NFkB (Niederman et al.
1992) and the lymphokine IL-2 (Luria, Chambers, and Berg, 1991). N-terminal
myristoylation and plasma membrane association are critica for p27 Nef function
(Allan et al. , 1985; Franchini et al. , 1986; Guy et al. , 1990; Kaminchik et al. , 1990
and 1991; Zazopoulous and Haseltie, 1992).
p27 Nef protein can also be phosphorylated by protein kinase C (PKC) at
Thr15 (Guy et al. , 1987 and 1990b; Nebreda et al. , 1991). The significance of this
phosphorylation is not known. However, there seems to be selective pressure
present both in vitro and in vivo to substitute Thr15 with an Ala. A long term
evolutionar study of Nef in an infected individual has reveaed high rates of
of?'
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substitution of Thr15 with an Ala with disese progression (Delassus et al. , 1991).
Nef-induced down-regulation of surface CD4 , inhibition of IL- l mRNA , and
inhibition of NFkB induction sem to be independent of phosphorylation by PKC
at this site. NU- Nef has an Ala at position 15.
Some evidence suggest that Nef may playa role as a signal transducer.
Strcturally, Nef has similarties to leucine zipper-like seuences found in
transcriptional factors (Samuel et al. , 1991) and ca interact with nuclea factors
that bind the Negative Regulatory Element of the HIV- LTR (Guy et al. , 1990a).
Thus , it may have the potential to influence the transcriptional activity of HIV -
LTR (Guy et al. , 1990b). Nef has also been reported to have homology to the
thyrotropin receptor (Burch et al. , 1991) as well as scorpion peptides that interact
with potassium channels in the brain (Werner et al. , 1991).
One study suggests that certn forms of Nef may be selected in chronic
virs producers (Zweig et al. , 1990). Stocks of HIV- IIIB contan sub-
populations of virses which express either a p25 or a p27 form of Nef. Both of
these forms are myristoylated and react with antibodies to the N-terminal peptide
of Nef. Thus , the two forms most likely reflect the presence of a mutation(s) that
affects the electrophoretic mobilty of the full length form of Nef. At low passage
(.c 8), ilB-infected cultures express both forms of Nef in about the sae ratios.
By contrast, at high passage ( loo) IIIB-infected cultures are enriched for virus
expressing the p25 form of Nef.
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Role of vpr an ne in cell cue. In cell culture, both 
vpr and net are
dispensable for virs replication. The presence of Vpr has been reported to
accelerate cytopathic effects (Cohen et al. , 1990b). It has also been shown to
increase virus replication in both T-cells and monocyte/macrophages (Ogawa et
al. , 1989; Cohen et al. , 1990b; Hattori et al. , 1990; Westervelt et al. , 1992). Vpr
ca somewhat increase the activity of the HI- LTR as well as the
trscriptional control elements of a number of other viruses. Effects of Vpr on
LTR activity do not involve Vpr binding to the LTR (Cohen et al. , 1990b).
The expression of Nef has a varety of effects on cells. These effects have
depended upon the use of speific aleles of nef, the multiplicity of infection , and
the taget cell line (reviewed in Hovanessian, 1992). Nef can have both a positive
and a negative effect on viral transcription and replication as well as no effect at
al. The inhibitory effects of Nef in vitro have implicated it in the establishment
of viral latency (Haseltine, 1991). However in vivo Nef seems to have a more
positive effect, as discussed below.
Role of vpr an ne in iricted anma: Most primar HIV -1 isolates
contan intact vpr and net genes suggesting that functional forms of these genes
confer a selective advantage to the virus in the infected host (Balfe et al. , 1990;
Delassus, Cheynier, and Wain-Hobson, 1991; Li et al. , 1991; Blumberg et al.
1992; Li et al. , 1992). In the SIV majrhesus monkey model, the presence of a
functional net has been shown to increase virulence. In studies with the infectious
molecular clone SIV 
mac239, a premature stop codon at the 93rd amino acid in net
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reverts to a sense codon within 2 weeks of inoculation into monkeys. Monkeys
inoculated with either the virus contaning the full length nef gene, or the stop
codon mutat, maintan high viral loads and develop immunodeficiency within
months of inoculation. However, monkeys inoculated with viruses contaning
deletions in nef (that canot revert by simple point mutation) have low vira loads
and remain heathy (Kestler et al. , 1991). Recnt results suggest that the same
may also be tre for lpr (Lg and Fleckenstein, 1992). Monkeys inoculate with
vpr stop codon mutats that do not revert have remained heathy and without
viremia in contrast to monkeys in which the stop codons reverted.
Low cytopathic potential does not ensre the efficient esblihment of
chronic vir producers. Temporal analyses of infections with the NI- mutats
reveaed that low cytopathicity does not necssaly correlate with the efficiency of
the establishment of chronic virus producers. Low cytopathicity appes to be a
prerequisite for the efficient establishment of chronic virs producers. This 
be seen by the fact that none of the mutats with high cytopathic potential could
- )
generate high levels of chronic virus producers (see NL4U and NL4U 4N in
Figure 26A). However, low cytopathicity was not sufficient for the efficient
establishment of chronic virus producers. This is best shown by the mutat
;;;
NL4R4U (Figure 26A and Table 5). NL4R4U had low cytopathic potential
, yet
it had only an intermediate efficiency of establishing chronic virus producers.
Analyses of the cultures transfected with the NI- mutats also reveaed
that the NI- backbone was more toxic for cells than HXB-2. Analysis of the
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growt potential of cells trsfected with the parenta and the mutat viruses
- showed that none of the Nl- based virses had the growth potential exhibite
by the uninfected or HXB-2-trsfecte cultures (Figure 26). Even cultures
transfected with mutats having a high abilty to establish chronic virus
producers, NLARAN and NLARAUAN, had only intermediate doubling times.
Vpu is not importnt in the esblihment of chronic vir producers.
Tests of the Nl- 3 mutats again reveaed that vpu was not importt in the
establishment of chronic virs producers. The presence of the vpu mutation in
the trple mutat, NLARAU AN, did not increase the abilty of this mutat 
establish chronic virs producers over that of the double mutat, NLAR AN (Table
5). Ths is puzzling since one would have predicted some involvement of a
defective vpu gene due to the highly selected nature of this defect in the varant
virses (Chapters I and II). Therefore, it is possible that the vpu defect was not
tested with the right combination of other genes to score for effects on chronic
virs production. Also , selection of the vpu defect in the varants may have
reflected the selection of varants in fully infected cultures. Assays on Nl-
mutats were initiated in spreading infections and did not select for the abilty of
a virs to emerge in a fully infected culture.
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INODUCTION
The studies presented in this chapter were underten to address the
possibl roles of non-auxilar gene sequences in the establishment of chronic
virs producers. HX-2 and Nl- contan many seuence differences in
addition to those that encode the defective vpr, vpu, and nef genes of HX-
These differences could have influence the relative abilty of 
Nl- 3 and HXB- 2
to establish chronic virs producers (Table 5).
To map the role of non-auxilar gene sequences, as well as auxilar gene
seuences, in the generation of chronic virus producers, six reciprocal
recombinants between Nl- and HXB-2 were constrcted using conserved
restrction sites. The recmbinants were designed to ensure that no region of
HX-2 was left out in the exchange process. Tests of the Nl- HX-
recombinants reveaed that 5' internal sequences (3' gag, pol, vif and 5' vpr), 
well as fragments encoding defective auxiiar genes , were importt for the
establishment of chronic virus producers.
REULTS
Use of NI3-HXB-2 recombinants to map sequences that affect the
esblihment of chronic virs producers. To test for effects of non-auxilar 
well as auxilar gene sequences on the generation of chronic virus producers
%Wc
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reciproc recombinants between NI- and HX-2 were constrcte and tested
for their abilty to establish chronic virus producers. The genomes and the
expression of vpr, vpu and net by these recombinants are ilustrted in Figure 28.
As with the NI- mutats, results of growth tests are summarzed by grouping
constrcts that encoded low (Figure 27A), intermediate (Figure 27B) and high
(Figure 27C) abilties to establish chronic virs producers.
Growth tests of cells trsfected with the NI- HXB-2 recombinants
reveaed effects of non-LTR seuences at the 5' end of the viral genome as well
as effects of 3' fragments contaning defective auxilar genes on the abilty to
establish chronic virus producers (Figures 27 and 28). In the presence of the 5'
internal ApaI to EcoRI fragment of NI- (nt 2006 to nt 5743 of NI- proviral
DNA), 3' HX- 2 fragment encoding defective vpr, vpu and net did not confer
high abilty to establish chronic virus producers (See NLHX- , Figures 27B and
28). Similarly, in the presence of 5' NI- sequences, HXB-2 3' fragment
encoding defective vpr and vpu did not confer high abilty to establish chronic
virs producers (see NLHX- , Figures 27B and 28B). However, when 5' internal
sequences were from HXB- , 3' HXB-2 fragments encoding defective vpr and vpu
(NHX-3) or defective net (NHX-5) were able to confer high abilty to establish
chronic virus producers (Figure 27C). The 5' internal HXB-2 fragment on its
own , however, was not sufficient to convert NI- into a high chronic virs
producer (see NLHX- , Figures 27A and 28B). Thus , in the recombinants, the
abilty to establish chronic virus producers was context dependent and required 5'
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internal HX-2 seuences as well as 3' HX- 2 fragments contaning defective
auxilar genes.
As with the NU- mutats (Table 5), the overa abilty to establish
chronic virus producers correlated with low cytopathicity in the infected cultures
(Figure 28). For example, recombinants NLHX-3 and NLHX-5 with high abilties
to establish chronic virs producers, were least cytopathic for cells in culture.
And recmbinant NLHX- , with low abilty to establish chronic virus producers
showed high cytopathic potential for cells in culture. Two of the three
recombinants with intermediate abilties to establish chronic virus producers
NLHX-4 and NLHX- , had intermediate cytopathic potential for cells in culture.
However, one exception to this overall trend was observed for the third
recombinant with intermediate abilty to establish chronic virus producers , NLHX-
2. In NLHX-2-transfecte cultures , low cell death did not correlate with the
efficient establishment of chronic virus producers (Figure 28).
In contrast to the NU- mutats , the NU- HXB-2 recombinants were
able to establish chronic virs producers that exhibited normal cell growth (Figure
27). Ths is shown by tests with NLHX - 3 and NLHX - 5 , the two recombinants
with the highest abilty to establish chronic producers (Figure 27C). Both NLHX-
3- and NLHX- transfected cultures had doubling times similar to those of the
uninfected or HXB-2-expressing H9 cultures.
Once again, the recombinants demonstrated that a long post-trsfection
lag was not required for the efficient establishment of chronic virus producers
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(Figure 28). Cultures trfected with NLHX-3 had only a one day lag over NI-
for the appeance of virs-expressing cells. In addition, the recombinants
demonstrted that certn HX-2 sequences may be importt in the generation
of the lag. Cultures transfecte with NLHX-5 showed the longest lag (five days)
in the appece of virus-expressing cells. Ths recombinant contans the gag-pol
and vif region of HXB-2 as well as the HX-2 LTRs. HX-2 LTRs alone did
not affect the length of the lag significantly, as sen by the recombinant NLHX-
(Figure 28B). Similarly, the 
gag-pol and vif region was not sufficient by itself to
affect the lag significantly (see NLHX- , Figures 27A and 28B). Thus , the gag-pol
and vif region of HXB- , in combination with the HXB-2 LTRs, was required for
the long post-transfection lag.
DISCUSSION
Involvement of HIV -1 sequences in the esblihment of chronic vir
producers. We have demonstrated that multiple regions of the mV-l genome
determie the abilty to generate chronic virs producers. For NI- infections
defective vpr and nef genes were sufficient to change the efficiency of the
generation of chronic virs producers from low to high (Figure 26 and Table 5).
For infections with NI- HXB-2 recombinants , 5' internal HXB-2 sequences as
well as 3' fragments contaning defective auxilar genes were required for the
efficient establishment of chronic virus producers (Figures 27 and 28).
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Context-dependent requirement for 5' internal seuences. Tests of the
recmbinants of NI- HXB-2 demonstrted that 5' internal seuences play an
importt role in the establishment of chronic virs producers. The role of 5'
seuences was context dependent, with 5' internal sequences of HX-2 requirng
the presence of 3' internal HXB- 2 fragments for the efficient establishment of
chronic producers (Figures 27 and 28). In the case of NLHX- , the 3' EcoRI
XhoI fragment contaned defective vpr and vpu genes (Figure 28). In the case of
NLHX- , the 3' fragment contaned a defective nef gene (Figure 28). In addition
to defects in auxilar genes , these 3' internal fragments also contaned a number
of other sequences that were different from those in the NI- genome (Table 3).
Thus , requirement for these 3' fragments suggests , but does not prove, that intact
auxiar genes limit the abilty of NI- HX-2 recmbinants to generate chronic
virs producers.
Role of gag sequnces in the establis1unt of chronic viru proders. The 5'
fragment of HXB-2 required for the generation of chronic virus producers
includes the last half of gag, all of pol and vi/ and the 5' end of vpr. Two
regions of this 3737 bp 5' fragment have been previously implicated in cytopathic
potential. The first of these involves the 3' end of gag and most of pol. This
region may contrbute to the highly virulent phenotyp of HIV- NDK (Spire et
al. , 1990; Hirsch et al. , 1992).
Role of vif in the establis1unt of chronic viru proers. The second
region in the 5' HXB-2 fragment that has been implicated in determining
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cytopathcity is vi! Vif enhances viral infectivity durig virs production in a cell-
line dependent manner (Fisher et al. , 1987; Strebel et al. , 1987; Sak et al. , 1991;
Fan and Pedan, 1992; Gabuzd et al., 1992). Delays in virus expression due to
deletions in vif ca increase the abilty to establish chronic virus producers (Sak
et al. , 1991). However , in the NI- mutats and NI- HX-2 recmbinants,
delayed virs expression was not a prerequisite for the efficient establishment of
chronic virus producers (Table 5 and Figure 28). Also, in cultures that did exhibit
delayed virs expression , the length of the delay did not correlate with whether vif
was from HXB-2 or NI- (see NLaRaN in Figure 26C and NLHX-5 in Figure
28B). Thus , if vii affects the abilty of NI- and HXB-2 to establish chronic
virs producers, these effects are context dependent and not necssaly associate
with delays in the appeance of virus expressing cells.
Low cytopathic potential is not a diect correlate of the abilty to esblih
chronic virs producers. These studies once again demonstrate that low
cytopathic potential is not sufficient, by itself, for the efficient establishment of
chronic virus producers. This is shown by the data for cells transfected with
NLHX-2. NLHX-2 had low cytopathic potential but por abilty to generate
chronic virus producers (Figures 27, and 28).
Env sequences do not determe the abilty to esblih chronic vir
producers. Env is a frequent determinant of the cytopathic potential of HN-
isolates (Sodroski et al. , 1986a; Cheng-Mayer et al. , 1990; Koga et al. , 1990;
Stevenson et aI. , 1990a; York-Higgins et aI. , 1990; Hoxie et al , 1991; KowaIski et
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al. , 1991; de Jong et al. , 1992). Interestigly, the abilty of the NU- HXB-
recombinants to generate chronic virus producers did not correlate with the
presence of HX- env sequences (Figure 28). The env sequences of NU- 3 and
HXB-2 are both derived from the HIV - IIff/LA V family of viruses (Bare-
Sinoussi et al. , 1983; Gallo et al. , 1984; Adachi et al., 1986). Env proteins of both
of these virses cause syncytia. Thus , the presence of syncytium-inducing Env
glycoproteins did not prevent the efficient establishment of chronic virus
producers. This is in agreement with results of Spire et al. , 1990 who found the
syncytium-inducing env of HIV- NDK not to be the major determinant of the
cytopathic potential of this virus.
SUY AN FU DIRCTIONS
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SUMY AN FU DIRCTIONS
Studies presented in ths thesis have reveaed the complex nature of the
abilty of HIV -1 to establish chronic virs producers. Mapping of genetic
determiants for the abilty to establish chronic virus producers reveaed that
multiple mv -1 genes and sequences affect this abilty. In the case of NI- 3
mutats, defects in two auxilar genes vpr and nef, were sufficient for the
efficient establishment of chronic virs producers. However
, tests of the NI-
HX-2 recombinants reveaed the additional influence of a 5' internal region.
This internal fragment contaned gag, pol, vif, and 
vpr sequences.
The complexity of these results shows that the abilty to establish chronic
virs producers is a multi-gene, multi-step phenomenon. Whether vpr, nef, and
the 5' internal sequences act together or independently is not known. It is
possible that the mechanism responsible for the establishment of chronic virs
producers requires certn steps which in one viral str may be met by one set
of factors (like defects in both vpr and nef in NI-3) and in another viral strn by
yet a different set of factors (like 5' internal sequences in combination with
defective auxiliar genes in NI- HXB-2 recombinants).
Roles of vpr, ne and the 5' internal sequences in the esblihment of
chronic virs producers. Our studies have suggeste that the establishment of
chronic virus producers was affected both by the cytopathic potential of the virus
and the growth potential of the infected cells. Viruses that had high cytopathic
IJ '
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potential with adverse effects on the growth potential of the host cells were por
chronic virs producers, while viruses with low cytopathic potential that did not
adversely affect the growth potential of the cells were goo chronic virs
producers. Although a decrease in cytopathcity was not sufficient, by itself, to
increase the abilty of a virus to establish chronic virus producers, it was a
prerequisite. Thus , lowering the cytopathic potential, and thereby influencing the
survival of the infected cells , may be the first step towards the establishment of
chronic virus producers.
The fact that a minimum of two defective proteins were required for the
enhancement of the abilty of NI- 3 to establish chronic virus producers suggests
that a second function may be involved in allowing a virs to become a chronic
virus producer. With low cytopathic potential being the first of these functions
the secnd may relate to factors that control cell growth such as those involved in
signalling pathways.
Cytopathic potental. 
The cytopathic potential of a virus can be affected by
many factors including: products encoded by the virs being directly toxic to the
cell (Stevenson et al. , 1988; Terwiliger et al. , 1989), products encoed by the virus
sequestering or disrupting host cell functions (Hoxie et al. , 1986; Koga et al.
1990), or the budding of large amounts of progeny virons disruptig the integrity
of host cell membranes (Lnard et al., 1988).
Both Vpr and 5' internal sequences have been noted for effects on
cytopathicity. Vpr has been shown to increase the rate of replication and
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cytopathicity in T-cells (Cohen et al., 1990b). 5' internal vir sequences have also
been shown to increase the cytotoxicity of HIV- l in T-cells (Hirsch et al. , 1992).
Thus , either of these could affect chronic virs production by affecting the
cytopathic potential of the virs. By contrst, most reported' effects of Nef have
affected cell signalling rather than viabilty.
Infected cell growth. The seond step towards the establishment of chronic
virus producers, goo growth of infected cells, could be modulated by the action
of vir proteins on cell signalling pathways. Such activities could prevent the
virus from establishing chronic virs producers by limiting the growth of infected
cells. For example, Nef has been shown to down regulate surface CD4 molecules
(Garcia and Miler, 1991), IL-2 mRNA (Luria, Chambers, and Berg, 1991), and
NFkB (Niederman et al. , 1992)-- factors importt for T-cell activation and
growth. In addition, Nef has been shown to have phosphorylation-
dephosphorylation activities whereby it could activate or deactivate importt
signaling pathways (Guy et aI. , 1987; Poulin and Levy, 1992). Very limited
studies have been done on the effects of Vpr on cell signalling pathways. Vpr
could affect cell signalling pathways through its reported abilty to affect factors
that trs-activate the HIV- LTR (Cohen et al. , 1990b). At this point, it is not
clea how 5' internal sequences might affect pathways that control cell growth.
Future diections. Now that we have an appreciation for the viraI proteins
and sequences involved in the establishment of chronic virus producers, in order
to' understad the mechanism , two approaches should be underten. The first is
130
to furter map the genetic determinants that are importt in the establishment of
chronic virs producers. The second is to ca out functional studies on Vpr and
Nef to test how these proteins directly affect cytopathicity and cell growth.
Genetic stes: Tests of the NI- mutats reveaed the importce of
Vpr and Nef in the establishment of chronic virs producers. Tests of the NI-
HX-2 recombinants reveaed the importce of 5' internal seuences (3' gag,
pol, vi/, and 5' vpr) plus 3' fragments encoding defective auxilar genes in the
establishment of chronic virus producers. Defining the critica sequences in 5' and
3' fragments in the NI- HXB-2 recombinants should allow a better
understading of the mechanism of chronic virs production, espeially in
complementation with what we already know for NI-3. In addition, it would be
helpful to better define the auxilar gene requirements of both NI- and HXB-
for chronic virs production. Experiments designed to define the genetic
determinants would include:
Furter mapping of the 5' internal sequences of HX-2 to identify
sequences that determine the abilty to establish chronic virs producers
Furter mapping of the 3' HXB-2 fragments to identify genes/sequences
that determine the abilty to establish chronic virus producers
Further testing of the role of mutations in the vpr and nef genes of NI-
in chronic virus producers by mutating the initiator codons of these genes
to eliminate possible effects of trncated trslation products on the
establishment of chronic virus producers
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Fuona Stues: Since we have identified two genes that are importt
in the establishment of chronic virus producers in NI- these ca be tested for
effects on cytopathicity and cell growth. Our data revea that the cytopathic
potential of the virus and the growth potential of infecte cells are both importt
for the generation of chronic virus producers. Thus, expression of Vpr, Nef, and
Vpr plus Nef proteins in H9 and Jurkat cells (cells that ca establish chronic virs
producers) should allow testing for the cytopathic effects of these proteins and the
effects of these proteins on cell growth.
Similarly, Vpr, Nef, and Vpr plus Nef ca be teste for cytopathc effects
and for effects on growth potential in cells that do not establish chronic virs
producers (such as A3.01). How these proteins interact with T-cell lines that
differ in their abilty to establish chronic virus producers may provide importt
insights into the roles of these genes in chronic virus production.
Severa lines of evidence suggest that Nef affects the expression of cell
surface signalling proteins. Thus , in order to understad the role of Nef (and
perhaps Vpr) in the establishment of chronic virus production, it would be
valuable to study the effects of Vpr and Nef on the expression of cell surface
markers as well as other signal transducing molecules importt in T-cell growth.
These would include molecules such as: CD4 , CD3 , TCR, CD45 , IL- , and
NFkB.
Along the same lines , defining the cell surface markers on populations of
cells that are found in the acute and the chronic phases of infection may yield
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importt information on the mechanism of how chronic virs producers are
generated. Preliminar data have aleady suggeste interestig differences
between these two cell populations (see Discussion to Chapter I).
Relevance of the phenomenon of chronic vi production to inected host.
The observation that defective auxilar genes are importt in the generation of
chronic virus producers may have some relevance to disease progression. Due to
the infidelity of the viral reverse transcriptase, mutat viruses are constatly
generated in the infected individual (Goodenow et al., 1989). Thus , over the
course of the immunodeficiency syndrome, perhaps chronic virus producers are
also continuously generated by cells harboring appropriate mutats. Since peple
infected with HIV -1 mount a significant immune response to the initial virus
infection , one would predict that chronic virus producers would be cleaed 
hosts with functioning immune systems. However, with disease progression
severe defects in the immune surveilance mechanisms of the infecte individual
develop. Therefore, in the later stages of the disease the immune system may not
be able to clea virus-expressing cells. In such patients, chronic virus producers
could act as factories of virus , exacerbating the onset and severity of disease.
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